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Abstract Astrocytes regulate the formation and function of neuronal synapses via multiple
signals; however, what controls regional and temporal expression of these signals during development is unknown. We determined the expression profile of astrocyte synapse-regulating genes in
the developing mouse visual cortex, identifying astrocyte signals that show differential temporal and
layer-enriched expression. These patterns are not intrinsic to astrocytes, but regulated by visually
evoked neuronal activity, as they are absent in mice lacking glutamate release from thalamocortical
terminals. Consequently, synapses remain immature. Expression of synapse-regulating genes and
synaptic development is also altered when astrocyte signaling is blunted by diminishing calcium
release from astrocyte stores. Single-nucleus RNA sequencing identified groups of astrocytic genes
regulated by neuronal and astrocyte activity, and a cassette of genes that show layer-specific enrichment. Thus, the development of cortical circuits requires coordinated signaling between astrocytes
and neurons, highlighting astrocytes as a target to manipulate in neurodevelopmental disorders.

Introduction
Synapses are points of contact where electrochemical signals are transferred between neurons in a
given circuit (Petzoldt and Sigrist, 2014; Südhof, 2018). Synapse development occurs in several
molecularly and functionally defined stages, which include initiation, maturation, and pruning steps
prior to stabilization and establishment of mature circuits. In the rodent cortex, this occurs over the
period of the first postnatal month, initiating at around postnatal day (P) 7, peaking at P14, and stabilizing towards P28 (Blue and Parnavelas, 1983a; Blue and Parnavelas, 1983b; Farhy-Tselnicker and
Allen, 2018; Li et al., 2010). Synaptic deficits, for example, caused by mutations in synapse-related
genes, are associated with developmental disorders such as autism spectrum disorder and epilepsy
(Lepeta et al., 2016). Therefore, understanding how synaptic development is regulated will provide
important insights into how circuits form and function in health and are altered in disease.
The majority of synapses in the mammalian cortex are contacted by astrocytes, a type of glia and
key regulators of circuit development and function (Allen, 2013; Batool et al., 2019; Bernardinelli
et al., 2014a; Genoud et al., 2006). Astrocytes express many genes encoding proteins that regulate distinct stages of synapse formation and maturation (Baldwin and Eroglu, 2017). For example,
thrombospondin family members induce formation of structurally normal but functionally silent
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synapses (Christopherson et al., 2005; Eroglu et al., 2009). Glypicans induce the formation of active
synapses by recruiting GLUA1 to the postsynaptic side (Allen et al., 2012; Farhy-Tselnicker et al.,
2017) and chordin-like 1 induces synapse maturation by recruiting GLUA2 to the postsynaptic side
(Blanco-Suarez et al., 2018). These and other signals have been identified using in vitro cell culture
approaches and analyzed individually across ages and brain regions in vivo. Yet, a systematic analysis
of their expression patterns in a complete circuit in vivo, which would reveal distinct regulatory roles
for specific synaptic connections, has not been attempted.
The mouse visual circuit is a well-characterized and powerful model to investigate the role of astrocytes in regulating different stages of synaptogenesis. Visual information perceived by the retina is
relayed to the visual cortex (VC) via the neurons of the thalamic lateral geniculate nucleus (LGN).
Before eye opening (from birth to ~P12 in mice), spontaneous retinal activity evokes correlated
cortical responses (Gribizis et al., 2019; Hanganu et al., 2006) that are important for the correct
establishment of thalamocortical synapses (Cang et al., 2005). Eye opening marks a step towards
synapse maturation in the VC, with the appearance of visually evoked neuronal responses across
the retinal-LGN-VC circuit (Espinosa and Stryker, 2012; Hooks and Chen, 2006; Hooks and Chen,
2020). Perturbing this process by methods of visual deprivation, such as dark rearing, delays both
synaptic (Albanese et al., 1983; Desai et al., 2002; Freire, 1978; Funahashi et al., 2013; Hsu et al.,
2018; Ishikawa et al., 2014; Ko et al., 2014; Majdan and Shatz, 2006; Tropea et al., 2006) and
astrocyte maturation (Müller, 1990; Stogsdill et al., 2017).
The VC’s glutamatergic neurons are arranged in spatially defined layers, with distinct transcriptomic, functional, and connectivity profiles (Bannister, 2005; Douglas and Martin, 2004). For
example, neurons in layers 1 and 4 receive input from the LGN, while layer 5 neurons, the main output
to subcortical regions, send their dendrites to layer 1, where they receive input from both local and
subcortical projections. Recent work has shown that cortical astrocytes are also spatially arranged in
diverse populations (Batiuk et al., 2020; Bayraktar et al., 2020; John Lin et al., 2017; Lanjakornsiripan et al., 2018), in line with evidence from other brain regions showing astrocyte heterogeneity
(Chaboub and Deneen, 2012; Chai et al., 2017; Khakh and Deneen, 2019; Oberheim et al., 2012;
Rusnakova et al., 2013; Schitine et al., 2015). However, whether this astrocyte diversity is reflected
in their regulation of synapses across the distinct layers of the VC is unknown. To understand how the
diverse astrocytic signals act together to regulate formation of a complete circuit, it is important to
determine both temporal and spatial expression patterns of astrocytic synapse-regulating genes in
vivo as well as identify the mechanisms that control their level of expression and the subsequent effect
on synapse formation.
Here, we use RNA sequencing and in situ hybridization to obtain the developmental transcriptome
of astrocytes in the mouse VC in vivo. We find that astrocyte synapse-regulating genes display differential temporal and spatial expression patterns, which correspond to stages of synapse initiation and
maturation. Furthermore, we find that developmental regulation of these genes, namely glypican 4
and chordin-like 1, depends on thalamocortical neuronal activity, with additional regulation by astrocyte IP3R2-dependent Ca2+ activity. Manipulating either neuronal or astrocytic activity leads to shifts in
synaptic development and maturation. Finally, single-nucleus RNA sequencing analysis reveals diverse
populations of astrocytes in the developing VC and identifies novel groups of genes that are regulated
by neuronal and astrocyte activity. These findings demonstrate how astrocyte expression of synapse-
regulating genes is controlled during development, and how synapse maturation is dependent on
neuron-astrocyte communication. These data further provide an important resource for future studies
of astrocyte development and astrocyte regulation of synapse formation.

Results
To address key questions regarding astrocyte regulation of synapse development, this study has three
major goals. First, to characterize the spatio-temporal profile of astrocyte development during distinct
stages of cortical synaptogenesis at the transcriptomic level. Second, to investigate the mechanisms
that influence spatio-temporal expression levels of select astrocytic synapse-regulating genes, focusing
on neuronal and astrocyte activity. Third, to determine the global dependence of the astrocyte transcriptome on neuronal and astrocyte activity using an unbiased RNA sequencing approach. All analyses were performed in the mouse VC to enable comparison of these metrics within a defined circuit,
providing a blueprint for future analysis of the functional roles of astrocytes in synaptic development.
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Developmental profiling of the astrocyte transcriptome in the
postnatal VC
Astrocytes appear in the cortex at birth, and migrate, proliferate, and mature throughout the first
postnatal month (Ge et al., 2012), coincidently with the stages of synapse development. To determine
the transcriptomic profile of astrocytes at these stages (P7, P14, P28, and adult, P120), we used the
astrocyte Ribotag mouse model to isolate mRNA for bulk RNA sequencing (B6N.129-Rpl22tm1.1Psam/J
crossed to B6.Cg-Tg(Gfap-cre)73.12Mvs/J – labeled Astrocyte-RiboTag) (Figure 1, Figure 1—figure
supplement 1, Figure 1—source data 1; Boisvert et al., 2018; Chai et al., 2017). In this mouse line,
cre recombinase drives the expression of an HA-tagged ribosomal subunit, enabling purification of
cell-type-specific ribosomes and associated mRNA for analysis by RNA sequencing (Figure 1A and B).
We found a significant enrichment in astrocytic genes over other cell types in the mRNA isolated by
HA immunopurification (IP; labeled Astro) compared to total VC mRNA (input; IN; Figure 1—figure
supplement 1A). Furthermore, immunostaining analysis of VC sections at P28 shows a high overlap
between the HA ribosome tag and the astrocyte marker S100β, but not with other cell-type markers
(Figure 1—figure supplement 1B-D), with more than 95% of S100β-positive cells also positive for
the HA tag, suggesting high astrocyte coverage of our mRNA isolation, consistent with our previous
analysis in the adult (Boisvert et al., 2018). The complete RNA sequencing dataset is available in a
searchable format online (http://igc1.salk.edu:3838/astrocyte_transcriptome/).
To assess if there are broad changes in the transcriptomic profiles of astrocytes across development, we performed principal component analysis (PCA; Figure 1C). This showed that P7 and P14
astrocytes form distinct clusters, while P28 and P120 astrocytes cluster together. To investigate this
further, we analyzed the number of differentially expressed genes (DEGs; fragments per kilobase of
exon per million mapped fragments [FPKM] > 1; false discovery rate [FDR] < 0.05) between each
age group. DEGs are classified into total genes (all changes detected), genes that are expressed
by astrocytes (IP/input > 0.75), and genes that are enriched in astrocytes (IP/input > 3; Figure 1D,
for definitions, see also Boisvert et al., 2018). The largest number of DEGs is between P7 and P28
(~6000 total genes), and smallest numbers between P14 and P28 (~1000 total genes), and P28 and
P120 (~2000 total genes). Analysis of astrocyte-enriched genes (IP/input > 3) showed that ~60% of
all astrocyte-enriched genes are significantly changed from P7 to P14, while only ~20% are changing
between P28 and P120 (Figure 1E). This shows that most changes in astrocyte gene expression are
occurring between the first and second postnatal weeks, a time of transition from synapse formation
to synapse maturation, and in the VC, from spontaneous to visually evoked neuronal activity.
To determine the different astrocyte functions at each age, we focused on the astrocyte-enriched
gene lists (~1000 total genes FPKM >1, astro IP/input > 3). To identify common genes expressed at all
ages, as well as astrocyte-enriched genes that are most highly expressed at each age, we performed
Gene Ontology (GO) analysis, focusing on Biological Process (BP) terms (Figure 1F–H, Figure 1—
figure supplement 1F and G). This showed that genes common to all ages are enriched in GO
terms related to cholesterol processing and serine synthesis, confirming the previously established
important role of astrocytes in regulating brain cholesterol (Orth and Bellosta, 2012; Figure 1G).
Analysis of GO terms unique to each age showed that at P7 astrocyte genes are enriched in GO terms
related to cortical development, while at P14 astrocyte genes are enriched in GO terms related to
Wnt and BMP signaling pathways. Conversely, adult astrocytes (P120) are enriched in terms related
to regulation of extracellular matrix assembly and contact inhibition (Figure 1H). In all we found both
the number of genes and the GO terms common to all ages constitute about 50% of all terms identified for each age, while genes and GO terms unique to each age consist less than 10% of all terms
(Figure 1—figure supplement 1F and G). These results demonstrate that astrocytes perform their
core functions across all developmental stages similarly, with several age-specific functions that turn
on and off depending on the developmental stage and the environment in the VC.
An important analysis to be performed with this dataset is determining the temporal expression
changes of known astrocyte genes, for example, to identify potential astrocyte markers that are either
global or age specific. We found that Apoe and Cst3 are the most highly expressed genes in astrocytes at all ages (peak FPKM ~10,000; Figure 1F, Figure 1—source data 1), while amongst highly
expressed astrocyte genes (FPKM >100) Lars2 is the most astrocyte-enriched gene at all ages (astro
IP/ input ~40; Figure 1—figure supplement 1E). These genes are highly expressed in adult astrocytes
across multiple brain regions (Morel et al., 2017), thus can be potentially utilized to mark or target
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Figure 1. Developmental profiling of the astrocyte transcriptome in the postnatal visual cortex (VC). See also Figure 1—figure supplement 1,
Figure 1—source data 1. (A) Outline of experiment: VCs from Rpl22-HAf/+; Gfap-cre 73.12 mice were collected at different time points corresponding to
synapse development and maturation, and subjected to Ribotag pulldown protocol, followed by RNA purification, library preparation and sequencing.
(B) Example images of VC at postnatal day (P)7 and P28 as labeled, showing colocalization between Ribotag (green, HA) and astrocyte marker S100β
Figure 1 continued on next page
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Figure 1 continued

(red). Scale bars = 20 μm. (C) Principal component analysis of RNAseq data shows P7 and P14 samples clustering separately from other ages, while P28
and P120 samples cluster together, suggesting similar gene expression profiles (N = 3 at P7, 4 at P14, 5 at P28, 3 at P120; for statistical comparisons,
3xP120 samples published in Boisvert et al., 2018 were added to increase the power of the analysis, giving an N = 6 P120). (D) Pairwise comparison
of differentially expressed genes (DEGs; red: upregulated; blue: downregulated) between each time point showing total genes (light hue, all DEGs
identified with FPKM >1), astrocyte expressed genes (darker hue, expression level in pulldown sample/input >0.75), and astrocyte-enriched genes (dark
hue, expression level in pulldown sample; astro/input >3). (E) Percent of all astrocyte-enriched genes that are differentially expressed between each age.
Percent DEGs is highest between P7 and P14. (F) Heatmaps of top 20 astrocyte-enriched genes at each age, sorted by expression level, along with 13
genes common to all time points (left), and top 5 most enriched genes at each age (right). Colors represent log2 FPKM of expression level. (G, H) Gene
Ontology (GO) terms analysis with String db of Biological Process (BP) in astrocyte-enriched genes at each time point. (G) Plot of GO terms common to
all time points with a gene ratio >0.5. (H) Plot of GO terms unique to each age with a gene ratio >0.5. Bar length is gene ratio, fill color is false discovery
rate (FDR). See also Figure 1—source data 1B. (I, J) Heatmaps of select genes related to astrocyte function (I) and synaptic regulation (J) plotted as
log2 fold change (FC) at each age relative to P120. * Adjusted p value (FDR) < 0.05 by DESeq2 with Benjamini–Hochberg’s correction when comparing
P120 to each age.
The online version of this article includes the following figure supplement(s) for figure 1:
Source data 1. Temporal profiling of astrocyte transcriptome in the postnatal visual cortex (VC).
Figure supplement 1. Developmental profiling of the astrocyte transcriptome in the postnatal visual cortex (VC).

astrocytes globally. The expression of another well-known astrocytic gene Aldh1l1 (Morel et al., 2017;
Figure 1I) is stable across all ages, making it an optimal marker for astrocytes during both development and in the adult (Srinivasan et al., 2016). On the other hand, S100b expression is upregulated
later in development, making it more suitable to mark adult astrocytes (Figure 1I). For genes that
encode proteins important for astrocyte function, we found that the metabotropic glutamate receptor
Grm5 (mGluR5) is most highly expressed at P7 and then declines with maturation, confirming previous
reports (Catania et al., 1994; Sun et al., 2013), while the glutamate transporter Slc1a2 (Glt1) and the
connexins (Gja1, Gjb6) are significantly upregulated from P14 onwards (Figure 1I).

Astrocytic synapse-regulating genes show differential spatio-temporal
expression patterns
Our goal is to characterize how astrocytes regulate synapses, so we next used the astrocyte Ribotag
dataset to investigate the developmental expression changes of key synapse-
regulating genes
(Figure 1J). These include astrocyte-secreted thrombospondins (Thbs), which induce silent synapse
formation. The family members expressed by astrocytes in the CNS show divergent expression, with
Thbs1 being significantly higher at P7 than later ages, whereas Thbs4 is significantly higher at P120
than P7 (Figure 1J). This temporal expression profile fits with previous studies that have demonstrated important roles for Thbs1 in initial synapse formation at P7 (Christopherson et al., 2005),
and suggested roles for Thbs4 in the adult brain (Benner et al., 2013). Similarly, glypican (Gpc) family
members have a divergent expression. Though redundant in culture for their ability to regulate immature synapse formation (Allen et al., 2012), Gpc4 and Gpc6 show different temporal expression in
vivo. While Gpc4 is most highly expressed at P7 and gradually declines with maturation, Gpc6 peaks
at P14–P28. Gpc5, a glypican family member with yet unknown function, has low expression at P7, and
is significantly increased at all later ages. Astrocyte-secreted chordin-like 1 (Chrdl1) regulates synapse
maturation and its expression peaks at P14, confirming previous analysis (Blanco-Suarez et al., 2018;
Figure 1J). These temporal expression profiles are not limited to factors that promote synapse formation. Astrocyte phagocytic receptors involved in synapse elimination, Megf10 and Mertk (Chung
et al., 2013), significantly increase in expression between P7 and P14, coincident with the initiation
of synapse elimination.
Our RNA sequencing analysis demonstrates that in the developing VC synapse-regulating genes
show differential temporal expression patterns. However, whether these levels are equal across astrocytes in all cortical layers throughout development is unknown. During the first postnatal weeks, when
astrocytes regulate synapse development, they are still migrating and dividing (Ge et al., 2012). Yet,
how developing astrocytes populate each of the cortical layers, and their ratio relative to other cortical
cells across development has not been quantified. To address this, we utilized the well-established
mouse line where astrocytes express GFP under the Aldh1l1 promoter (Cahoy et al., 2008; Dougherty et al., 2010; John Lin et al., 2017; Stogsdill et al., 2017; Tien et al., 2012). Immunostaining of
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brain sections from Aldh1l1-GFP mice at P7 and P28 with antibodies against known astrocyte markers
ALDH1L1, S100β, and SOX9 showed high overlap between GFP and marker-positive cells, suggesting
the majority of astrocytes in the VC express GFP in this mouse line (Figure 2—figure supplement
1A–C), further validating its usage. We quantified astrocyte numbers within each of the six neuronal
layers at the developmental time points, which correspond to astrocyte and synapse development
throughout the first postnatal month (P1, P4, P7, P14, P28; Figure 2A–C). At birth (P1), very few
astrocytes are present, comprising 0.5–2% of the total cell number in the VC (represented as GFP-
positive cells as a percentage of all cells marked by the nuclear dye DAPI), with a significantly higher
percentage of astrocytes in deeper layers than upper layers (Figure 2C and D, Figure 2—source data
1A). The astrocyte percentage increases with development in all cortical layers, peaking at P21–P28.
At this time, astrocytes are ~10% of total cell number in layers (L) 2–6, and ~50% in L1 (Figure 2C and
D, Figure 2—source data 1A). As the brain develops, the distance between cells grows to accommodate the increase in cell size and complexity, as evident by a significant decrease in DAPI-positive
nuclei per mm2 of VC that occurs from P1 to P14–P28 (Figure 2—figure supplement 1D, Figure
2—source data 1A). Despite this decrease in total cell density, the proportion of astrocytes remains
constant in all cortical layers and across ages, with the exception of L1–2/3, where it is significantly
lower at P1 (Figure 2C and E). This stability in astrocyte density is likely explained by new astrocytes
still being generated in the weeks after birth (Ge et al., 2012).
Having established the developmental profile of astrocytes, we next determined if there are layer-
specific developmental changes in mRNA expression of synapse-regulating genes by performing
single-molecule fluorescent in situ hybridization (smFISH; RNAscope) on brain sections of Aldh1l1-GFP
mice. We probed for seven genes that regulate distinct aspects of synaptogenesis: active synapse-
regulating – glypicans (Gpc) 4, 5, 6; synapse maturation regulating – chordin-like 1 (Chrdl1); and silent
synapse-regulating – thrombospondins (Thbs1, 2, 4) (Figure 2F–M, Figure 2—figure supplement 2,
Figure 2—source data 1B and C). Expression of each gene (represented as total area of thresholded
signal in µm2; labeled as thresh area) was analyzed within the territory of GFP-positive astrocytes
in each cortical layer at similar time points as above: P4, P7, P14, and P28, when most alterations
in astrocyte transcriptome (Figure 1) and synapse development occur (Farhy-Tselnicker and Allen,
2018), and excluding P1, when the numbers of astrocytes in the cortex are very low. A negative
control probe was used to determine the minimal signal threshold of detection (Figure 2—figure
supplement 2H and I).
We first analyzed glypicans, factors that promote active synapse formation. Bulk RNAseq (Ribotag)
showed that Gpc4 expression by astrocytes is highest at P7 and gradually declines with maturation
(Figure 1J, Figure 1—source data 1A). Layer-specific analysis, however, shows that these differences
are driven by astrocytes in L1: Gpc4 expression decreases between P7 and P14 only in L1 astrocytes,
staying stable across development in all other layers (thresh area [μm2] L1: P4 3.1 ± 0.5; P7 4.1 ± 0.1;
P14 1.7 ± 0.2; P28 1.1 ± 0.3; Figure 2F and G, Figure 2—source data 1B and C). Gpc6, on the other
hand, peaks at P14–P28 in bulk sequencing. Layer-specific analysis showed that this increase occurs in
astrocytes between P7 and P14 in L2–5, with significant upregulation in L5, and remaining high at P28
(thresh area [μm2] L5: P4 2.5 ± 0.4; P7 2.5 ± 0.4; P14 4.4 ± 0.4; P28 3.1 ± 0.4; Figure 2H and I, Figure
2—source data 1B and C). Gpc5 is strongly upregulated at P14 and remains high at P28 in astrocytes
in all layers, matching the bulk RNAseq data (thresh area [μm2] L1: P4 0.5 ± 0.1; P7 1.3 ± 0.2; P14 5.9
± 0.7; P28 5.3 ± 1.1; Figure 2J and K, Figure 2—source data 1B and C).
The expression of the synapse maturation factor Chrdl1 peaks at P14 in the bulk RNAseq data
(Figure 1J, Figure 1—source data 1A). Spatial analysis revealed that this increase from P7 to P14
is layer-specific, with the largest increase in Chrdl1 occurring in upper layer astrocytes with significant upregulation in L2/3 (thresh area [μm2] L2/3: P4 4.1 ± 0.2; P7 4.1 ± 1; P14 9.9 ± 0.6; P28 7.6 ±
1; Figure 2L and M, Figure 2—source data 1B and C). Further, at its peak of expression, Chrdl1
is highest in L1–4 astrocytes compared to L5–6, demonstrating a heterogeneous expression across
layers, as previously reported (Bayraktar et al., 2020; Blanco-Suarez et al., 2018). Finally, we analyzed
astrocyte thrombospondins, factors that induce silent synapse formation (Figure 2—figure supplement 2B-G). Thbs mRNA levels in the VC are much lower at their peak expression than glypicans or
Chrdl1, consistent with our bulk RNAseq results (Figure 1J, Figure 1—source data 1A), and previous
studies showing low thrombospondin expression in the resting state, and an upregulation by learning
or injury (Nagai et al., 2019; Tyzack et al., 2014). Nevertheless, we observed an increase in Thbs2
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Figure 2. Astrocytic synapse-regulating genes show differential spatio-temporal expression patterns. See also Figure 2—figure supplements 1 and
2, Figure 2—source data 1. (A) Schematic of experiments described in Figures 2–3: visual cortex (VC) sections from Aldh1l1-GFP mice analyzed
for astrocyte numbers, gene expression, and synaptic proteins at developmental time points as indicated. (B) Diagram of VC depicting neuronal
(blue) laminar arrangement and connectivity (arrows). Astrocytes (green) are present in all layers. (C–E) Astrocyte number increases in the VC across
Figure 2 continued on next page
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Figure 2 continued

development. (C). Example images of the VC from Aldh1l1-GFP mice at time points analyzed. GFP marks astrocytes (green), DAPI (magenta) labels
nuclei. Layers (L) labeled by numbers on the right in each panel. (D) Quantification of (C), astrocytes as a percentage of total cells within each cortical
layer. (E) Quantification of (C), number of astrocytes per mm2 of VC within each layer. Scale bar in (C): 50 μm; N = 4 mice for postnatal day (P)1; N =
3 mice for P4–P28. Graphs show mean ± s.e.m., red squares are average of individual mouse. *p≤0.05, **p<0.01, ***p<0.001, ns (not significant) by one-
way ANOVA comparing expression between time points within each layer; see also Figure 2—source data 1A. (F–M) Synapse-regulating genes show
differential spatio-temporal expression patterns. (F, H, J, L) Example images showing Gpc4, Gpc6, Gpc5, or Chrdl1 mRNA (white) in astrocytes (green) at
each age and layer as labeled. Merged panel on the left, single-channel probe panel on the right. (G, I, K, M) Quantification of (F, H, J, L), respectively.
(F) Gpc4 expression is reduced at P14 specifically in L1. (H) Gpc6 expression is increased at P14 in L5. (J) Gpc5 expression is increased at P14 in all layers.
(L) Chrdl1 expression is increased at P14 in L2/3. Scale bars in (F, H, J, L) = 20 μm. Arrowheads in single-channel panel mark astrocyte cells on the left. N
= 3 mice/age for each probe. Data presented as scatter with mean + range. Green dots are mRNA signal measured in individual astrocytes. Large circles
colored according to age are average signal. N = 3 mice/age, n = ~50–350 astrocytes/per age total; averages and statistical analysis are calculated
based on N = 3, i.e., data per mouse. *p≤0.05, **p<0.01, ***p<0.001, ns (not significant) by one-way ANOVA comparing expression between time points
within each layer. See also Figure 2—source data 1B and C.
The online version of this article includes the following source data and figure supplement(s) for figure 2:
Source data 1. Astrocytic synapse-regulating genes show differential spatio-temporal expression patterns.
Figure supplement 1. Astrocytic synapse-regulating genes show differential spatio-temporal expression patterns.
Figure supplement 2. Astrocytic synapse-regulating genes show differential spatio-temporal expression patterns.

expression in L4–5 at P28 (thresh area [μm2] L5: P4 0.7 ± 0.1; P7 0.7 ± 0.19; P14 1 ± 0.1; P28 1.8 ± 0.3;
Figure 2—figure supplement 2D and E, Figure 2—source data 1B); and an increase in Thbs4 at P28
in all layers (thresh area [μm2] L1: P4 0.1 ± 0.01; P7 0.1 ± 0.1; P14 0.3 ± 0.1; P28 1.9 ± 0.5; Figure 2—
figure supplement 2F and G, Figure 2—source data 1).
The seven astrocyte synapse-regulating genes we analyzed using smFISH all regulate formation
and function of excitatory glutamatergic synapses. In the case of Gpc4, Gpc6, and Chrdl1, they
regulate glutamatergic synapse development by primarily affecting localization of AMPA glutamate
receptor (AMPAR) subunits (Allen et al., 2012; Blanco-Suarez et al., 2018). Previous studies in the
rat somatosensory cortex have identified developmental alterations in AMPAR subunit expression
(Brill and Huguenard, 2008; Kumar et al., 2002); however, their spatio-temporal expression patterns
in the developing mouse VC, and whether these correlate with the expression of astrocytic genes
that regulate them, have not been systematically analyzed (Figure 3A and B). To detect postsynaptic
AMPA glutamate receptors, we stained for GLUA1 and GLUA2 subunits (Figure 3C–F, Figure 3—
source data 1). To detect the corresponding glutamatergic presynaptic terminals, we stained for
VGLUT1 to identify local cortico-cortical connections (Figure 3G and H, Figure 3—figure supplement 1A, Figure 3—source data 1) and VGLUT2 to identify thalamocortical connections (Figure 3I
and J, Figure 3—figure supplement 1B, Figure 3—source data 1; Fremeau et al., 2001). As
expected based on the literature, GLUA1 levels peak at earlier time points than GLUA2 (Figure 3C
and D, Figure 3—source data 1). GLUA2 immunoreactivity significantly increases from P7 to P14 in
L1–5, and then remains stable to P28 (Figure 3E and F, Figure 3—source data 1). At all ages, the
levels of GLUA1 and GLUA2 are significantly higher in L1 than all other layers, consistent with L1
being rich in synaptic connections (Figure 3—source data 1; Douglas and Martin, 2004). VGLUT1
immunoreactivity greatly increases between P7 and P14 in all cortical layers and remains stable at
later ages (Figure 3G and H, Figure 3—figure supplement 1A, Figure 3—source data 1). VGLUT2
levels steadily increase from P1 to P14, and then remain stable. VGLUT2 immunoreactivity is significantly higher in L1 and L4 than other layers at all ages, consistent with these being thalamic innervation zones and previous findings in rat cortex (Figure 3I and J, Figure 3—figure supplement 1B,
Figure 3—source data 1; Boulland et al., 2004; Conti et al., 2005; Fremeau et al., 2001; Lopez-
Bendito and Molnar, 2003). Taken together, these data show that synaptic proteins show complex
spatio-temporal expression patterns, with multiple significant changes occurring between P7 and P14,
as also observed for astrocyte gene expression.
In summary, the transcriptomic analysis reveals significant changes in astrocyte gene expression
across development, with the most prominent changes occurring between P7 and later ages, a time
between synapse initiation and maturation. We have further determined the spatio-temporal expression profile of key astrocyte synapse-regulating factors, identifying divergent developmental and
layer-specific expression patterns within the same families of genes. These findings strongly suggest
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Figure 3. Spatio-temporal profiling of synaptic protein expression in the postnatal visual cortex (VC). See also Figure 3—figure supplement 1,
Figure 3—source data 1. (A) Schematic of experiments described in Figures 2–3: VC sections from Aldh1l1-GFP mice analyzed for astrocyte numbers,
gene expression, and synaptic proteins at developmental time points as indicated. (B) Diagram of VC depicting neuronal (blue) laminar arrangement
and connectivity (arrows). Astrocytes (green) are present in all layers. (C–F) Developmental expression pattern of the postsynaptic AMPARs GLUA1
and GLUA2 subunits within each cortical layer. (C, E) Example images of GLUA1 or GLUA2 protein levels (white puncta). (D, F) Quantification of (C,
E) number of GLUA1 or GLUA2 puncta per cortical volume (μm3). GLUA1 expression is increased from postnatal day (P)1 to P28 in all layers. GLUA2
expression is increased from P1 to P28 in all layers, and between P7 and P14 in L1–5. (G–J) Developmental expression pattern of the presynaptic
proteins VGLUT1 and VGLUT2 in each cortical layer. (G, I) Example images of VGLUT1 or VGLUT2 protein levels (white puncta). (H, J) Quantification
of (G, I) density of VGLUT1 or VGLUT2 signal as total area of thresholded signal per μm2. VGLUT1 expression increases in all layers between P7 and
P14. VGLUT2 expression increases steadily from P1 to P28 in L1 and L4. Scale bars = 10 μm. N = 3 mice/age. Graphs show mean ± s.e.m., red squares
average of individual mouse. *p≤0.05, **p<0.01, ***p<0.001, ns (not significant) p>0.05 by one-way ANOVA comparing expression between time points
Figure 3 continued on next page
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Figure 3 continued
within each layer.
The online version of this article includes the following figure supplement(s) for figure 3:
Source data 1. Spatio-temporal profiling of synaptic protein levels.

Figure supplement 1. Spatio-temporal profiling of synaptic protein expression in the postnatal visual cortex (VC).

that astrocyte expression of synapse-regulating genes is closely tied to the developmental stage of
the cortex, which features both changes in neuronal and astrocyte activities across development.
In addition to revealing important information about the developmental changes in expression of
synapse-regulating genes, these transcriptomic data can be further utilized to inform further studies
on astrocyte development. The complete dataset and GO term list are available in Figure 1—source
data 1.

Thalamic glutamate release tunes astrocyte expression of synapseregulating genes
Having found broad differences in astrocyte expression of synapse-regulating genes across cortical
layers, we next asked what are the possible physiological mechanisms that regulate these layer-
specific alterations between P7 and P14 in the developing VC in vivo. Our experiments using cultured
astrocytes and neurons show that GPC4 protein secretion from astrocytes is significantly reduced in
the presence of neurons (Figure 4—figure supplement 1A, Figure 4—figure supplement 1—source
data 1) or when astrocytes are incubated with neurotransmitters including glutamate, adenosine, or
ATP (Figure 4—figure supplement 1B, Figure 4—figure supplement 1—source data 1). Others have
reported a similar effect on Gpc4 mRNA expression (Hasel et al., 2017), suggesting that neuronal
activity can influence expression and release of synapse-regulating factors from astrocytes. Indeed,
significant alterations in the activity patterns of both glutamatergic and GABAergic neurons occurs
in the VC at around P14 (Espinosa and Stryker, 2012). Since the developmental expression changes
in Gpc4 and Chrdl1 occurred mostly in the upper cortical layers innervated by thalamic neurons,
we hypothesized that levels of these genes may be regulated by changes in the activity of thalamic
neurons that occur upon eye opening at ~P12, when there is a transition from spontaneous to visually
evoked activity in the retina that is relayed via the thalamus to the VC.
To investigate this, we generated mice where the release of glutamate from thalamocortical terminals in the VC is perturbed by knocking out the vesicular glutamate transporter VGlut2 (Slc17a6) from
neurons in the dLGN. Knockout of VGlut2 has been previously shown to abolish presynaptic release
of glutamate in VGlut2-expressing neurons, in full or conditional knockout mouse models (Wallén-
Mackenzie et al., 2010). We crossed Slc17a6f/f mice (Slc17a6tm1Lowl/J; labeled as VGlut2 WT) to an
RORα cre line (Roratm1(cre)Ddmo; Slc17a6f/f;cre labeled as VGlut2 cKO), where cre recombinase is expressed
in thalamic neurons including the dLGN (Figure 4A; Chou et al., 2013; Farhy-Tselnicker et al., 2017).
Immunostaining experiments showed a significant decrease in VGLUT2 signal in the VC of VGlut2
cKO mice compared to WT at P14 (Figure 4B). Notably, VGlut2 cKO did not strongly affect the levels
of VGLUT1, which marks cortico-cortical connections (Figure 4C; Wallén-Mackenzie et al., 2010),
though a small but significant increase in VGLUT1 immunoreactivity was observed in L4, a major target
of thalamocortical projections. This suggests that the normal upregulation in VGLUT1 that occurs at
P14 across all other cortical layers (Figure 3) is either intrinsic to the cortical neurons and/or regulated
by mechanisms other than dLGN-VC-evoked activity.
A lack of VGLUT2 immunoreactivity in the VC could also result from an absence of thalamic axons
innervating their target regions. To test whether that is the case, we crossed RORα cre and VGlut2
cKO mice with a tdTomato reporter line (B6.C-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J; labeled as tdTomato)
to visualize dLGN axons (Figure 4A). All cre+ tdTomato+ groups (VGlut2 WT (Slc17a6+/+), VGlut2 cHet
(Slc17a6f/+), and VGlut2 cKO (Slc17a6f/f)) showed a comparable number and volume of tdTomato-
labeled projections in L1 and L4 of the VC (Figure 4—figure supplement 2A and B). Analysis of
VGLUT2 puncta colocalized with tdTomato-positive axons showed a significant decrease in number in
VGlut2 cHet and VGlut2 cKO compared to WT (Figure 4—figure supplement 2A, C). These results
show that in the VGlut2 cKO mice thalamic axons are present at their target layers in the VC but lack
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Figure 4. Thalamic glutamate release tunes astrocyte expression of synapse-regulating genes. See also Figure 4—figure supplements 1 and 2,
Figure 4—source data 1. (A) Schematic of the experiment: VGLUT2 is removed from presynaptic terminals of neurons in the lateral geniculate nucleus
of the thalamus (LGN) that project to the visual cortex (VC) by crossing Slc17a6 f/f mouse (WT) with RORαcre mouse line (VGlut2 cKO). Bottom: image
of tdTomato reporter expression in the LGN and the VC, when RORαcre mouse is crossed with cre-dependent tdTomato reporter mouse (Ai14). (B)
Figure 4 continued on next page
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VGLUT2 level in the VC is significantly reduced in VGlut2 cKO mice. Example images of VGLUT2 immunostaining in each genotype and quantification
of the thresholded signal within each cortical layer. (C) VGLUT1 level is unaltered in VGlut2 cKO mice. Example images of VGLUT1 immunostaining
and quantification. In (B, C), plots show mean signal ± s.e.m. Squares and circles above each bar are the average of signal in each mouse. N = 5 mice/
genotype. Scale bar = 50 μm. Statistical analysis by t-test within each layer. p-Value on each plot. (D–I) mRNA expression of astrocyte synapse-regulating
genes is altered in VGlut2 cKO at postnatal day (P)14. (D, F, H) Example images of in situ hybridization of Gpc4, Gpc6, and Chrdl1 mRNA (white) as
labeled; astrocyte marker Slc1a3 (Glast, green). Merged panel on the left, single-channel probe panel on the right. (E, G, I) Quantification of (D, F, H),
respectively. (E) Gpc4 mRNA expression is increased in L1; (G) Gpc6 mRNA expression is decreased in L4–6. (I) Chrdl1 mRNA expression is decreased
in L1–4 in VGlut2 cKO mice. Data presented as scatter with mean + range. Gray or red dots are mRNA signals measured in individual astrocyte in WT
and VGlut2 cKO, respectively. Large circles are the average signal. N = 5 mice/genotype, n = ~200–450 astrocytes/per age total (average and statistical
analysis are calculated based on N = 5, i.e., per mouse). Arrowheads in single-channel panel mark astrocytes. Scale bar = 20 µm. See also Figure 4—
source data 1. Statistical analysis by t-test within each layer. p-Value on each plot. (J–M) Increase in GLUA1 protein levels and colocalization between
GLUA1 and VGLUT1 in L1 of the VC in VGlut2 cKO mice compared to WT at P14. (J) Example images from WT (top) and cKO (bottom), VGLUT1 in cyan
and GLUA1 in red. (K–M) Quantification of VGLUT1, GLUA1, and colocalized puncta, respectively, normalized to WT. (N–Q) Decrease in GLUA2 protein
levels and colocalization between GLUA2 and VGLUT1 in L1 of the VC in VGlut2 cKO mice compared to WT at P14. (N) Example images from WT (top)
and cKO (bottom), VGLUT1 in cyan and GLUA2 in red. (O–Q) Quantification of VGLUT1, GLUA2, and colocalized puncta, respectively, normalized to WT.
In (K–M) and (O–Q), data presented as mean ± s.e.m., squares and circles above each bar are mean fold change of each mouse. N = 5 mice/genotype.
Arrowheads mark representative colocalized puncta in (J, N). Inset panels on the right show enlarged colocalized image from box in (J, N). Scale bar =
5 µm. In (J–Q), WT is Slc17a6 +/+; RORαcre+;tdTomato+; cKO is Slc17a6 f/f;RORαcre+;tdTomato+. Statistical analysis by t-test, p-value on each plot.
The online version of this article includes the following figure supplement(s) for figure 4:
Source data 1. Neuronal activity regulates astrocytic expression of synapse-regulating genes.
Figure supplement 1. Thalamic glutamate release tunes astrocyte expression of synapse-regulating genes.
Figure supplement 1—source data 1. Neuronal activity regulates astrocytic expression of synapse-regulating genes.
Figure supplement 2. Thalamic glutamate release tunes astrocyte expression of synapse-regulating genes.

VGLUT2, as has been shown in studies performing similar manipulations, suggesting that they are
functionally silent (Li et al., 2013; Zechel et al., 2016).
Does the lack of thalamocortical glutamate release influence the expression of synapse-regulating
genes in astrocytes? To address this, we performed smFISH probing for Gpc4, Gpc6, or Chrdl1, along
with a probe for the glutamate transporter Slc1a3 (Glast) (Ullensvang et al., 1997) to label astrocytes
(Figure 4D–I, Figure 4—figure supplement 2D–J, Figure 4—source data 1). The number of cortical
astrocytes marked by Slc1a3, and the expression level of Slc1a3 mRNA, is not affected by VGlut2
cKO in any cortical layer at P14, showing that gross astrocyte development proceeds normally in the
absence of thalamic input (Figure 4—figure supplement 2D and E). During normal development,
Gpc4 expression significantly decreases between P7 and P14 specifically in L1 astrocytes (Figure 2F
and G). In VGlut2 cKO mice, this change no longer occurs (Figure 4D and E). Gpc4 expression
is significantly increased in VGlut2 cKO compared to WT at P14 specifically in L1 astrocytes and
unchanged in all other layers (thresh area [μm2]: L1 WT 1.3 ± 0.1; cKO 2.3 ± 0.2; Figure 4D and E,
Figure 4—source data 1). Gpc6 expression is normally increasing in astrocytes in deep layers between
P7 and P14 (Figure 2H and I). In the absence of thalamic glutamate release, Gpc6 is lower in astrocytes in layers 4 and 5 than in the WT at P14, showing that the normal developmental upregulation has
been blocked (thresh area [μm2]: L4 WT 2.7 ± 0.4; cKO 1.5 ± 0.1; Figure 4F and G, Figure 4—source
data 1). Similarly, Chrdl1 expression normally increases in upper layer astrocytes between P7 and P14
(Figure 2L and M); however, it is significantly decreased in VGlut2 cKO compared to WT specifically
in astrocytes in upper layers (1–4), and not affected in deep layers at P14 (thresh area [μm2]: L1 WT 6
± 0.4; cKO 4.6 ± 0.5; Figure 4H and I, Figure 4—source data 1). To determine if these alterations
are due to the loss of thalamic neuron glutamate release at a specific developmental time (e.g., eye
opening at ~P12), we analyzed the expression of Gpc4, Gpc6, and Chrdl1 at P7 (prior to eye opening).
We found no difference in expression of any of these genes (Figure 4—figure supplement 2H–J), nor
any difference in the number of cortical astrocytes marked by Slc1a3, or the expression level of Slc1a3
mRNA (Figure 4—figure supplement 2F and G). These results show that during VC development
from P7 to P14 glutamate release from thalamic neurons regulates the developmental expression of
astrocyte Gpc4, Gpc6, and Chrdl1 in a layer-specific manner.
Are there any consequences of decreased glutamate release and subsequent altered expression
of astrocyte synapse-regulating genes on synaptic development? To address this, we performed
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immunostaining for pre- and postsynaptic proteins in VGlut2 cKO mice and their WT controls in L1 of
VC at P14. We first analyzed cortico-cortical synapses marked by VGLUT1 and found that, as in the
low-resolution characterization (Figure 4C), there is no change in VGLUT1 puncta in the absence of
VGLUT2 (Figure 4J, K, N and O). In the case of GLUA1 containing AMPARs, which are regulated by
Gpc4, we found a significant increase in the number of GLUA1 puncta and their colocalization with
VGLUT1 in the VGlut2 cKO, correlating with the observed increase in Gpc4 (GLUA1 FC 1.24 ± 0.04;
Figure 4J and L; Coloc FC 1.38 ± 0.07; Figure 4J and M). For GLUA2 containing AMPARs, which
are regulated by Chrdl1, we found a significant decrease in both the number of GLUA2 puncta and
the number of colocalized GLUA2-VGLUT1 puncta in VGlut2 cKO mice compared to WT, correlating
with the observed decrease in Chrdl1 (GLUA2 FC 0.77 ± 0.04; Figure 4N and P; Coloc FC 0.75 ±
0.1; Figure 4N and Q). We asked if similar effects are also present at thalamocortical synapses. Since
VGLUT2 is absent in cKO mice, we used Slc17a6f/f; RORαcre;tdTomato (labeled as VGlut2 cKO; tdTomato) to
label thalamic axons (Figure 4A, Figure 4—figure supplement 2A) and identified presynaptic active
zones within tdTomato axons by immunostaining for the presynaptic marker Bassoon (Figure 4—
figure supplement 2K and O). We found no difference in the number of Bassoon puncta colocalized
with tdTomato between the WT and cKO mice, a further indication that synapses form in the absence
of VGLUT2 (Figure 4—figure supplement 2K, L, O, P), and fitting with findings from mice that globally lack presynaptic release (Verhage et al., 2000). As is the case for cortico-cortical synapses, we
found an increase in GLUA1 and colocalization of GLUA1 with Bassoon and tdTomato (GLUA1 FC 1.21
± 0.09; Figure 4—figure supplement 2K and M; Coloc FC 1.36 ± 0.23; Figure 4—figure supplement 2K and N), and a decrease in total GLUA2 and GLUA2-Bassoon synapses (GLUA2 FC 0.70 ±
0.08; Figure 4—figure supplement 2O and Q; Coloc FC 0.65 ± 0.13; Figure 4—figure supplement
2O and R).
These results show that synaptic GLUA1 and GLUA2 levels are altered in VGlut2 cKO VC in the
direction which follows the change in astrocytic expression of Gpc4 (which recruits GLUA1) and Chrdl1
(which recruits GLUA2) in L1. These correlated changes in astrocyte genes and synaptic proteins
suggest a disruption in synapse maturation in the VC at P14 in the absence of thalamocortical glutamate release that may be mediated by astrocytes.

Astrocytic calcium signaling tunes expression of synapse-regulating
genes
Since we observed that changes in thalamic glutamate release influence the expression of astrocyte
synapse-regulating genes, we next asked how perturbing the astrocyte response to neurotransmitters
affects the expression of Gpc4, Gpc6, and Chrdl1. Astrocytes express many neurotransmitter receptors, in particular GPCRs, and respond to neurotransmitters with increased intracellular calcium (Kofuji
and Araque, 2021; Porter and McCarthy, 1997). In the case of somal increases in calcium, which
have the potential to regulate expression of activity-regulated genes, most of this increase is mediated by the release of calcium from intracellular stores via IP3R2 (Itpr2) (Srinivasan et al., 2015). We
therefore asked if blunting astrocyte calcium signaling by removing store-mediated calcium release
using Itpr2 KO mice (Itpr2tm1.1Chen; labeled Ip3r2 KO; Figure 5A and B) has an impact on the expression
of synapse-regulating genes.
To determine this, we performed smFISH on the VC of P14 Ip3r2 KO and WT mice, marking astrocytes with a probe against Slc1a3 along with Gpc4, Gpc6, or Chrdl1. At P14, knocking out Ip3r2
does not affect the number of astrocytes or the expression levels of Slc1a3, showing astrocytes
develop grossly normally when store-mediated calcium release is diminished (Figure 5—figure
supplement 1A and B, Figure 5—source data 1, Figure 5—source data 2). However, loss of IP3R2
does affect expression of synapse-regulating genes. In the case of Gpc4, the mRNA level is reduced
in astrocytes in all layers, with a significant decrease occurring in L1, 4, and 6 (thresh area [μm2]:
L1 WT 1.5 ± 0.1; KO 1.1 ± 0.1; Figure 5C and D, Figure 5—source data 1). For Gpc6, there is no
difference in the mRNA level between Ip3r2 KO and WT in astrocytes in any layer (Figure 5E and F,
Figure 5—source data 1). Chrdl1 expression is increased in astrocytes in all layers, with a significant
increase occurring in L1, 2/3, and 5 (thresh area [μm2]: L1 WT 7.3 ± 1.1; KO 10.6 ± 1; Figure 5G and
H, Figure 5—source data 1). To ask if these alterations are present throughout development, we
performed the same analysis at P7. As with P14, at P7 there is no change in astrocyte number or
Slc1a3 mRNA signal, showing astrocytes develop grossly normally (Figure 5—figure supplement
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Figure 5. Astrocytic calcium signaling tunes expression of synapse-regulating genes. See also Figure 5—figure supplement 1, Figure 5—source
data 1 and 2. (A) Schematic of comparison. Lack of the IP3R2 receptor results in diminished Ca2+ transients in astrocytes. (B) Validation of Itpr2 KO
model. Western blot image shows absence of IP3R2 signal in visual cortex (VC) of KO mice. (C–H) mRNA expression of astrocyte synapse-regulating
genes is altered in Ip3r2 KO mice at postnatal day (P)14. (C, E, G) Example images of in situ hybridization of Gpc4, Gpc6, and Chrdl1 mRNA (white) as
Figure 5 continued on next page
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Figure 5 continued

labeled; astrocyte marker Slc1a3 (Glast, green). Merged panel on the left, single-channel probe panel on the right. (D, F, H) Quantification of (C, E, G),
respectively. (D) Gpc4 mRNA expression is decreased in several layers of the VC in Ip3r2 KO mice. (F) Gpc6 mRNA expression is unaltered in the VC
in Ip3r2 KO mice. (H) Chrdl1 mRNA expression is increased in several layers of the VC in Ip3r2 KO mice. Data presented as scatter with mean + range.
Gray or purple dots are mRNA signals measured in individual astrocyte in WT and Ip3r2 KO, respectively. Large circles colored according to genotype
are average signal. N = 5 mice/genotype, n = ~200–450 astrocytes/per age total (average and statistical analysis are calculated based on N = 5, i.e., per
mouse). Arrowheads in single-channel panel mark astrocytes. Scale bar = 20 μm. Statistical analysis by t-test within each layer. p value on each plot. (I–L)
Decrease in VGLUT1, GLUA1 protein levels, and colocalization between GLUA1 and VGLUT1 in L1 of the VC in Ip3r2 KO mice at P14. (I) Example images
from WT (top) and KO (bottom), VGLUT1 in cyan and GLUA1 in red. (J–L) Quantification of VGLUT1, GLUA1, and colocalized puncta, respectively,
normalized to WT. (M–P) Decrease in VGLUT1, and increase GLUA2 protein levels, with no change in colocalization between GLUA2 and VGLUT1 in
L1 of the VC in Ip3r2 KO mice at P14. (M) Example images from WT (top) and KO (bottom), VGLUT1 in cyan, and GLUA2 in red. (N–P) Quantification of
VGLUT1, GLUA2, and colocalized puncta, respectively, normalized to WT. In (J–L) and (N–P), data presented as mean ± s.e.m. squares and circles above
each bar are mean fold change of each mouse. N = 5 mice/genotype. Arrowheads mark representative colocalized puncta. Inset panels on the right
show enlarged colocalized image from box in (M). Scale bar = 5 µm. Statistical analysis by t-test, p-value on each plot.
The online version of this article includes the following figure supplement(s) for figure 5:
Source data 1. Astrocyte calcium activity regulates astrocytic expression of synapse-regulating genes.
Source data 2. Astrocyte calcium activity regulates astrocytic expression of synapse-regulating genes.
Figure supplement 1. Astrocytic calcium signaling tunes expression of synapse-regulating genes.

1C and D). In the case of Gpc4 and Chrdl1, there is no difference in expression between Ip3r2 KO
and WT at P7 (Figure 5—figure supplement 1E and G), whereas for Gpc6 there is a significant
increase in the Ip3r2 KO restricted to L4 (Figure 5—figure supplement 1F). Therefore, in contrast
to the layer-specific alterations in gene expression in the VGlut2 cKO mice, removing IP3R2 impacts
astrocytes in all layers and does not strictly follow the developmental trajectory. This suggests a
broad requirement for astrocyte calcium signaling in all astrocytes to maintain the correct level of
gene expression, and that the signals to do this come from multiple sources and are not restricted
to thalamic inputs.
Are there any consequences of diminished astrocyte calcium signaling and altered expression
of synapse-regulating genes on synaptic development? As with the VGlut2 cKO, we addressed this
by performing immunostaining for presynaptic terminals (VGLUT1 or VGLUT2) and postsynaptic
AMPAR subunits (GLUA1 or GLUA2) in Ip3r2 KO mice and WT controls in L1 of VC at P14. We
found that the numbers of both cortico-cortical presynaptic terminals marked by VGLUT1, and thalamocortical terminals marked by VGLUT2, are significantly decreased in Ip3r2 KO mice compared
to WT, demonstrating a global deficit in synapse formation in the absence of astrocyte calcium
signaling (VGLUT1 from GLUA1: FC 0.86 ± 0.04; Figure 5I and J; VGLUT1 from GLUA2: FC 0.87 ±
0.05; Figure 5M and N. VGLUT2 from GLUA1: FC 0.89 ± 0.05; Figure 5—figure supplement 1H
and I; VGLUT2 from GLUA2: FC 0.80 ± 0.05; Figure 5—figure supplement 1L and M). For GLUA1
containing AMPARs, which are regulated by Gpc4, we found a significant decrease in the total
number of puncta and their colocalization with VGLUT1 and VGLUT2 in the Ip3r2 KO, correlating
with the observed decrease in Gpc4 mRNA (VGLUT1-GLUA1: GLUA1 FC 0.84 ± 0.03; Figure 5I
and K; Coloc FC 0.70 ± 0.03; Figure 5I and L; VGLUT2-GLUA1: GLUA1 FC 0.83 ± 0.03; Figure 5—
figure supplement 1H and J; Coloc FC 0.74 ± 0.03; Figure 5—figure supplement 1H and K). For
GLUA2 containing AMPARs, which are regulated by Chrdl1, we found a significant increase in their
number, correlating with the observed increase in Chrdl1 (VGLUT1-GLUA2: GLUA2 FC 1.22 ± 0.07;
Figure 5M and O; VGLUT2-GLUA2: GLUA2 FC 1.14 ± 0.03; Figure 5—figure supplement 1L and
N). The number of colocalized presynaptic puncta and GLUA2 is, however, unchanged, likely due
to the opposing decrease in presynaptic puncta and increase in GLUA2 (VGLUT1-GLUA2 Coloc FC
1.09 ± 0.1; Figure 5M and P; VGLUT2-GLUA2 Coloc FC 1.00 ± 0.08; Figure 5—figure supplement
1L and O).
These results show that GLUA1 and GLUA2 levels are altered in Ip3r2 KO VC in the direction which
follows the change in astrocytic expression of Gpc4 (which recruits GLUA1) and Chrdl1 (which recruits
GLUA2). This strongly suggests that both astrocytes and neurons play an important role in regulating
the expression of synapse-regulating genes, and subsequently AMPAR subunit protein levels, and the
final expression levels arise from the complex interaction between these two cell types.

Farhy-Tselnicker et al. eLife 2021;10:e70514. DOI: https://doi.org/10.7554/eLife.70514



15 of 43

Developmental Biology | Neuroscience

Research article

Unbiased determination of astrocyte transcriptomic diversity and
activity-regulated genes in the developing VC
Having found that multiple synapse-regulating genes in astrocytes show layer-specific enrichment,
and that these patterns are regulated by neuronal and astrocyte activity, we next asked if these
findings are specific to synapse development, or if other astrocyte genes show a similar pattern.
To address this using an unbiased approach, we performed single-nucleus RNA sequencing of glial
cells isolated from the P14 VC of wild type, VGlut2 cKO, and Ip3r2 KO mice. To isolate the glial cell
populations, we immunostained VC nuclei in suspension with an antibody against the neuronal marker
NeuN and performed FACS to select the NeuN-negative population (Figure 6A). We used the Chromium 10X system to isolate individual glial nuclei and performed RNA sequencing to quantify mRNA
levels (Figure 6A). This identified 22,781 cells in the VGlut2 condition (cKO and WT) (Figure 6B,
Figure 6—figure supplement 1A) and 21,240 cells in the Ip3r2 condition (KO and WT) (Figure 6—
figure supplement 1B and C). Initial clustering analysis determined 17 distinct cell populations in
both models, with the majority of cells detected clustered within the main glial cell types: astrocytes,
microglia, and oligodendrocyte lineage cells (Figure 6B, Figure 6—figure supplement 1A–C). Just
two clusters enriched for neuronal markers are present (Hernandez et al., 2019), showing that the
NeuN depletion had been successful. This dataset is available in a searchable format online (https://
cells.ucsc.edu/?ds=mouse-astro-dev; Speir et al., 2021 ).

Astrocytes in the wild-type VC form transcriptomically diverse
populations
We focused our downstream analysis on astrocytes. A second round of unbiased clustering of the
astrocyte population identified four groups (Figure 6C, Figure 6—figure supplement 2A) in each
model and genotype. By comparing the genes enriched in each cluster with datasets in the literature,
we determined these to anatomically correspond to upper (L1–2/3), middle (mid; L2/3–5), deep (L5–6)
layer, and white matter (WM) astrocytes (Figure 6C, Figure 6—figure supplement 2A; Batiuk et al.,
2020; Bayraktar et al., 2020; Lanjakornsiripan et al., 2018). Similar cell numbers were identified in
each group across models and genotypes (number of nuclei in VGlut2 cKO model: upper 1114 WT;
1065 cKO, mid 1289 WT; 1163 cKO, deep 440 WT; 466 cKO, WM 273 WT; 268 cKO; Figure 6—figure
supplement 2C). We also determined the fractions of astrocytes present in each group and found that
this corresponds to the fractions we identified via anatomical cell counts (Figure 6—figure supplement 2D), showing that the process of nuclear isolation has captured astrocytes in levels that reflect
their in vivo abundance. To validate the layer-enriched genes, we took advantage of publicly available
in situ hybridization datasets generated by the Allen Brain Institute (Allen Brain Institute, 2008; available from https://developingmouse.brain-map.org/). Cross-referencing cluster-enriched genes identified in our study with P14 in situ hybridization datasets, we found that the gene Kcnd2 is expressed in
mid cortical layers, Id3 is enriched in deep layers, and Gfap is enriched in white matter, matching the
snRNAseq (Figure 6—figure supplement 2B).
Pairwise comparisons between each of the clusters using the WT astrocytes of each model as the
input cells showed that the most robust differences are between the deep and upper layer astrocytes, with over 700 DEGs and up to sixfold log2 FC in expression level (Figure 6D, Figure 6—figure
supplement 2E, Figure 6—source data 1A and B). On the other hand, upper and mid astrocytes
are the most similar, with about 200 DEGs and twofold log2 FC maximal difference in mRNA level
(Figure 6D, Figure 6—figure supplement 2E, Figure 6—source data 1A and B). GO terms analysis
of genes enriched in each cluster identified between 300 and 600 terms significantly enriched per
cluster, with 140 terms that are common to all four clusters, and between 40 and 120 terms that are
unique to each cluster (Figure 6—figure supplement 2F, Figure 6—source data 1C). Terms with
the highest gene ratio in the upper astrocyte cluster include pathways related to signal transduction
and membrane biogenesis (Figure 6—figure supplement 2G), whereas mid astrocytes are enriched
in terms related to GABAergic signaling and PSD95 clustering. Genes belonging to the deep astrocyte cluster are enriched in GO terms related to the regulation of pre- and postsynapse organization
(Figure 6—figure supplement 2F), while WM astrocyte genes are enriched with pathways related to
axonal guidance, maintenance, and signaling (Figure 6—source data 1C). Importantly, while there
are differences in astrocyte gene expression across layer groups, these are mostly gradients of gene
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Figure 6. Unbiased determination of astrocyte transcriptomic diversity and activity-regulated genes in the developing visual cortex (VC). See also
Figure 6—figure supplements 1–3, Figure 6—source data 1. (A) Outline of experiment: VCs collected from VGlut2 cKO, Ip3r2 KO, and their
respective WT controls at postnatal day (P)14. Nuclei were isolated from VCs and sorted for NEUN-negative population (glia) using flow cytometry.
Sorted nuclei were loaded onto 10X Chromium chip, each nucleus barcoded, followed by library preparation and sequencing. N = 8 samples total. (B)
Figure 6 continued on next page
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Figure 6 continued

UMAP clustering of different cell types identified in the NEUN-negative population of the combined samples from VGlut2 WT and cKO mice. 17 clusters
were identified including the three main types of glia: astrocytes, oligodendrocytes, and microglia, as well as endothelial cells, and two subtypes of
neurons. (M-astrocyte: mitotic astrocyte; M-OPC: mitotic oligodendrocyte precursor cell; OPC: oligodendrocyte precursor cell; MFOL: myelin-forming
oligodendrocyte; NFOL: newly formed oligodendrocyte; MOL: mature oligodendrocyte; VLMC: vascular and leptomeningeal cell; EC: endothelial cell;
PC: pericyte; PVM: perivascular macrophage). (C) Unbiased clustering analysis identified four subpopulations of astrocytes in the P14 VC. Upper panels:
left – UMAP plots of astrocyte populations annotated to upper, mid, deep, and white matter types following comparison with published datasets. Right
panel – UMAP showing similar clustering obtained for WT and VGlut2 cKO groups. Lower panel shows the expression level of select marker genes
that label a particular population as indicated. Each dot represents a single nucleus, color represents expression level in log2 counts per million reads
mapped (CPM). Below are dot plots showing a select list of 10 genes that are highly expressed in each population as indicated. Size of the circle is
expression ratio (percent cells expressing the gene); color is expression level (log2 CPM). (D) Pairwise comparison identified ~200–700 differentially
expressed genes (DEGs) between astrocyte populations from WT mice from the VGlut2 cKO model. Larger numbers of DEGs are obtained when
comparing upper and deep astrocyte populations. Criteria for DEG selection: log2 fold change (FC) between –0.15 and 0.15; false discovery rate (FDR) <
0.1; see also Figure 6—source data 1A and B. (E–H) Neuronal and astrocyte activity perturbation results in gene expression changes in astrocytes. (E)
Number of DEGs identified for each model: VGlut2 cKO: 61 total DEGs; Ip3r2 KO: 131 total DEGs as labeled. Red: upregulated; blue: downregulated.
(F, G) Heatmap showing top 20 DEGs identified in each model (F, VGlut2 cKO; G, Ip3r2 KO). Colors represent log2 FC between each condition. Criteria
for DEG selection: log2 FC between –0.15 and 0.15; FDR < 0.1. See also Figure 6—source data 1D. (H) Venn diagrams show number of DEGs common
to both models. Heatmap shows FC of the 19 common DEGs. Most common DEGs are inversely regulated in each model (upregulated in VGlut2 cKO
and downregulated in Ip3r2 KO). (I) Venn diagram showing DEGs common to the VGlut2 cKO vs. WT comparison and genes enriched in astrocyte layer
groups. Heatmap of expression level z score of a select list of 10 genes shows dysregulation of layer enrichment in the cKO mice compared to WT. Z-
score was calculated for each gene using the combined data for WT and cKO average and standard deviation. (J) Same analysis as (I), but for the Ip3r2
KO model. See also Figure 6—source data 1E.
The online version of this article includes the following figure supplement(s) for figure 6:
Source data 1. Unbiased determination of astrocyte layer-enriched genes and global astrocyte gene expression changes following silencing of
neuronal or astrocyte activity.
Figure supplement 1. Unbiased determination of astrocyte transcriptomic diversity and activity-regulated genes in the developing visual cortex (VC).
Figure supplement 2. Unbiased determination of astrocyte transcriptomic diversity and activity-regulated genes in the developing visual cortex (VC).
Figure supplement 3. Unbiased determination of astrocyte transcriptomic diversity and activity-regulated genes in the developing visual cortex (VC).

expression, suggesting that the astrocyte layer groups are on a continuum rather than distinct cell
types (Figure 6C, Figure 6—figure supplement 2A; Bayraktar et al., 2020; John Lin et al., 2017).
Next, we asked how astrocyte marker, function, and synapse-regulating genes highlighted in the
bulk RNAseq dataset (Figure 1G and H) are expressed across layers (Figure 6—figure supplement
2I and J). Overall, we found a positive correlation between levels of gene expression obtained by
the two sequencing methods, meaning that genes that were shown to be highly expressed in the
bulk dataset (such as ApoE) were also highly expressed in the snRNAseq dataset (Figure 6—figure
supplement 2I). Unsurprisingly, sequencing of bulk RNA samples was more sensitive in detecting the
low expressed genes, such as Gpc4, Tgfb1, and Thbs1, which were close to the detection threshold
in the snRNAseq dataset, precluding statistical analysis. Nevertheless, plotting the total counts per
million mapped reads (CPM) levels for Gpc4, Gpc6, and Chrdl1 revealed that they matched the spatial
analysis performed at the same age (Figure 3). Gpc4 expression is lowest in the upper layer cluster,
Chrdl1 expression is highest in the upper layer cluster, while Gpc6 levels are similar across all four
populations (Figure 6—figure supplement 2J). For other astrocyte marker, function, and synapse-
regulating genes detected in the snRNAseq dataset, most exhibited similar levels of expression in
all layer groups, with some notable exceptions. For example, Gfap and Aqp4 expression is higher in
deep and WM astrocytes than in upper and mid groups, while the expression of connexin 43 (Gja1)
is highest in deep layer astrocytes compared to all other groups (Figure 6—figure supplement 2I).
Taken together, these results show that wild-type astrocytes are transcriptomically diverse, but not
distinct, in the developing VC, in accordance with previous studies in which astrocyte diversity was
assessed at a similar developmental stage (Bayraktar et al., 2020).

Neuronal and astrocyte activity induces global transcriptomic changes
in astrocytes
Given that we found that astrocyte synapse-regulating genes are regulated by both neuronal and astrocyte activity, we next asked what other astrocyte genes are affected by these activity manipulations.
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To increase the power of our analysis, we combined the four astrocyte subpopulations into one group
for each genotype and used this combined group to identify DEGs between the WT and KO. We
found 61 DEGs for the VGlut2 cKO model and 131 DEGs for the Ip3r2 KO model (Figure 6E–H,
Figure 6—source data 1D). Performing the same analysis on two other abundant glial populations,
OPCs and microglia, showed 28 DEGs for OPCs and 24 DEGs for microglia in the VGlut2 cKO model,
and 38 DEGs for OPCs and 29 DEGs for microglia in the Ip3r2 KO model (not shown), 20–50% of the
astrocyte DEG level. This suggests that astrocytes are more sensitive to neuronal activity changes, as
well as more profoundly affected by silencing their calcium activity. GO analysis of astrocyte DEGs
in both models revealed a broad range of BPs, which go beyond terms that may be associated with
synapse regulation, such as ‘response to stimulus,’ ‘cell communication,’ or ‘retrograde axonal transport.’ For example, DEGs in the VGlut2 cKO model are also enriched for BP terms related to nuclear
envelope disassembly, and nitric oxide metabolism in the upregulated genes, and copper and zinc
ion processing in the downregulated genes (Figure 6—figure supplement 3A, Figure 6—source
data 1G). In the Ip3r2 KO model, upregulated genes are enriched for organic acid biosynthesis, while
downregulated genes are enriched in histone modification-related BPs (Figure 6—figure supplement
3B, Figure 6—source data 1G).
Next, as our smFISH analysis of Gpc4, Gpc6, and Chrdl1 showed that they are regulated in opposite ways by neuronal and astrocyte activity (Figures 4 and 5), we asked whether the DEGs identified
by snRNAseq show any overlap between the two models. We found a total of 19 DEGs common to
both the VGlut2 cKO and Ip3r2 KO models (Figure 6H, Figure 6—source data 1D). Only one gene
was commonly upregulated, and only three genes commonly downregulated (21% of total common
DEGs), while the remaining 15 genes showed opposing changes, similar to Gpc4 and Chrdl1 (79%
of common DEGs; Figure 6H heatmap). The same effect of opposing changes is observed when
the overlap between the enriched GO terms was compared (Figure 6—figure supplement 3C). For
example, the term ‘intracellular signal transduction’ (GO:0035556) is enriched in the downregulated
gene list in the VGlut2 cKO model, whereas in the Ip3r2 KO model it is enriched in the upregulated
gene list (Figure 6—figure supplement 3C, Figure 6—source data 1G).
Since we found that neuronal but not astrocyte activity is important for regulating layer-specific
expression of Gpc4, Gpc6, and Chrdl1 (Figure 2, Figure 4 and Figure 5), we next asked if this is true
for other DEGs identified in the snRNAseq dataset in each model (Figure 6I and J). To address this,
we compared the list of neuronal or astrocyte activity-regulated genes with the list of layer-enriched
genes from the WT (Figure 6I and J, Figure 6—source data 1E) and identified 43 common genes
in the VGlut2 cKO model (70% of all cKO/WT DEGs; Figure 6I) and 101 common DEGs in the Ip3r2
model (77% of all KO/WT DEGs; Figure 6J). In contrast to our expectation of finding layer-dependent
expression changes only in the VGlut2 cKO model, we found that in each model a subset of genes
show a dysregulated layer expression when activity is altered. For example, expression of Mapk10 is
lowest in WM astrocytes in the WT; however, in astrocytes from the VGlut2 cKO Mapk10 is upregulated in WM astrocytes compared to deep (Figure 6I). Similarly, the expression of Pde10a in the
Ip3r2 KO model WT group is higher in the upper astrocyte group than other groups, while in the KO
the level in that group is now low (Figure 6J). WT expression of the gene Gm47283 is higher in the
upper than deep layer group, while in the VGlut2 cKO, Gm47283 is upregulated in all groups, and
the relative expression between layers is maintained (Figure 6I). A similar pattern is observed in the
Ip3r2 KO model for the gene Stk38I (Figure 6J). Thus, perturbation of neuronal or astrocyte activity
influences the layer enrichment of some but not all genes, without causing gross rearrangement of
overall astrocyte spatial identity.
Further, while the expression of Gpc4, Gpc6, and Chrdl1 shows opposite levels in VGlut2 cKO mice
to those seen during normal development (Figure 4), astrocyte activity does not regulate these genes
in the same way (Figure 5). To test if this is a general phenomenon beyond synapse-regulating genes,
we took advantage of the bulk RNAseq dataset (Figure 1, Figure 1—source data 1A) and calculated the FC in gene expression of WT astrocytes between the time points P7 and P14 (FC P14/P7;
Figure 6—figure supplement 3D and E, Figure 6—source data 1F). We compared the DEG lists of
VGlut2 cKO and Ip3r2 KO models against the genes that are significantly up- or downregulated at P14
compared to P7 in the bulk data in search for common genes (Figure 6—figure supplement 3D and
E). This identified 30 DEGs from the VGlut2 cKO dataset (52% of all cKO/WT DEGs, Figure 6—figure
supplement 3D) and 57 genes from the Ip3r2 KO dataset (44% of all KO/WT DEGs, Figure 6—figure
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supplement 3E). Comparing the direction of expression changes between normal development and
the VGlut2 cKO DEGs, we observed that 70% of common genes were regulated in the opposite direction (Figure 6—figure supplement 3D, middle panel), similar to Gpc4, Gpc6, and Chrdl1 (Figure 4),
suggesting strong dependence of astrocyte developmental maturation on neuronal cues. On the
other hand, Ip3r2 KO data showed 50% of genes displaying the same directionality as during normal
development, and the other 50% showing the opposite regulation (Figure 6—figure supplement
3E). Taken together, these results show that during development astrocyte-neuron communication
enacts global gene expression changes in astrocytes, going beyond synapse-regulating genes.

Discussion
In this study, we demonstrate how astrocytes and synapses develop together in the postnatal mouse
VC, signaling to one another to ensure correct development (Figure 7). In particular, we show that:
•
•
•
•
•

expression of select synapse-regulating genes (Gpc4, Gpc6, and Chrdl1) is differentially regulated during development at both temporal and spatial levels
astrocyte transcriptome changes during development are correlated to expression changes in
some synaptic proteins
expression of astrocyte synapse-regulating genes is affected by changes in thalamic neuronal
activity and astrocyte calcium activity
astrocytes form heterogeneous populations in the developing cortex, based on their spatial
location
neuronal and astrocyte activity regulates multiple non-overlapping genetic programs in astrocytes, suggesting effects beyond synapse regulation.

Astrocyte number and transcriptome alterations across development
coincide with stages of synapse development
In the mouse cortex, astrocytes begin to be generated right before birth and populate the cortex
throughout the first month of life (Farhy-Tselnicker and Allen, 2018; Ge et al., 2012). During this time,
many changes are occurring in astrocytes, as well as in the synapses between neighboring neurons. We
observed that the most significant change in astrocytes at the transcriptome level occurred between
the first and second postnatal weeks (Figure 1). Similarly, an analysis of the synaptic proteome during
development showed the largest difference between P9 and P15 (Gonzalez-Lozano et al., 2016),
suggesting similar or overlapping regulatory mechanisms in both astrocytes and neurons. In addition
to the transcriptomic changes, astrocyte numbers are also strongly regulated during development.
Indeed, genes upregulated at P14 are uniquely enriched in GO terms related to cell proliferation and
migration (Figure 1—source data 1B). Interestingly, the density of astrocytes remains fairly constant
throughout development, suggesting that their expansion rate is correlated with the overall expansion of the brain tissue. The mechanisms that regulate these migration patterns are still unknown and
seem to be largely unaffected by neuronal or astrocyte activity, as evident from the similar numbers
of astrocytes within each cortical layer in both neuronal and astrocyte activity manipulation models
tested here (Figure 4—figure supplement 2, Figure 5—figure supplement 1). Future studies will
determine the factors or sets of factors that regulate the number and location of astrocytes within
defined domains.

Astrocytes form diverse populations in the developing mouse VC
The diversity of neurons based on location, morphology, connectivity, and activity patterns has been
extensively studied for decades, with multiple subtypes of excitatory and inhibitory neurons identified (Kepecs and Fishell, 2014; Migliore and Shepherd, 2005; Zeisel et al., 2015). For a long time,
cortical protoplasmic astrocytes were viewed as a homogeneous population. However, recent studies
looking in-depth at astrocyte heterogeneity using both bulk and single-cell sequencing approaches
have shown that within the cortex astrocytes form a heterogeneous population (Batiuk et al., 2020;
Bayraktar et al., 2020; Lanjakornsiripan et al., 2018). Unlike neurons, astrocytes do not fall into the
six-layer categories, but rather exist on a gradient of transcriptomically separable yet overlapping
groups. Indeed, our snRNAseq data shows that the biggest differences are between astrocytes of
the upper and deep layer groups, while upper and mid-layer groups are the most similar (Figure 6C
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Figure 7. Summary of key findings and working model. Box 1. Astrocytes and synapses develop across a similar time line in the mouse visual cortex
(VC). Left diagram: majority of astrocyte transcriptomic changes (represented as number of differentially expressed genes [DEGs]) occur between
postnatal day (P)7 (synapse initiation) and P14 (synapse maturation). Right diagram: select astrocytic synapse-regulating genes (Gpc4 and Chrdl1)
and synaptic proteins (GLUA1, GLUA2) are differentially expressed between P7 and P14. Box 2. The spatio-temporal expression of astrocyte synapse-
Figure 7 continued on next page
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Figure 7 continued

regulating genes is driven by thalamic neuronal activity and astrocyte calcium activity. Left: diagram of VC depicting neuronal (blue) laminar arrangement
and connectivity (arrows). Astrocytes (green) are present in all cortical layers. Right: expression of astrocytic Gpc4 and Chrdl1 mRNA, and their regulated
synaptic GLUAs during development. Gpc4 expression is decreased at P14, Chrdl1 expression is increased (correlating with increase in GLUA2 subunits,
which are regulated by Chrdl1). These changes are regulated by thalamic neuronal activity in a time- and layer-specific manner. Additionally, overall
expression of astrocytic genes is regulated by astrocyte calcium signaling. Box 3. Single-cell transcriptomic profiling of VC astrocytes at P14 reveals a
heterogeneity of gene expression, with a global transcriptomic dependence on neuronal and astrocyte activity. Left: UMAP plot shows four different
astrocyte clusters identified in the wild-type VC, which correspond to spatial organization in the cortex. Right: diagram showing layer-specific expression
of select astrocytic genes as labeled.

and D, Figure 6—figure supplement 2A and E). Nevertheless, we have identified several astrocyte population marker genes (such as Dcc or Kcnd2; Figure 6, Figure 6—figure supplement 2B,
Figure 6—source data 1A and B), which are significantly enriched in one group over others. Before
performing functional studies based on these genes, further characterization is required, for example,
cross-referencing these genes with our bulk RNA sequencing dataset to identify astrocyte-enriched
genes and performing immunohistochemistry (IHC) to determine if protein expression is also heterogeneous. These validated genes could then be used to target specific populations of astrocytes,
similar to the methods employed for neurons, in order to manipulate astrocytes that interact with
specific synapse types or circuits. Importantly, while blocking thalamocortical activity did alter the
expression of multiple genes in astrocytes, it did not alter the layer patterning of the cells, showing
that this is not a major factor in driving layer-enriched gene expression. Indeed, altering the identity of local cortical neurons by using Dab1 KO mice, in which cortical layer neurons are reversed,
does alter astrocyte layer identity, suggesting a role for local cues (Lanjakornsiripan et al., 2018).
Our findings further suggest that neuronal activity acts to fine-tune the level of astrocyte genes that
are important for neuronal function, rather than determining their presence or absence. Functional
studies are further needed to identify the precise neuronal activity patterns that govern astrocyte-
neuron reciprocal communication.
Moreover, some of the synapse-regulating genes we profiled display layer-specific expression
changes across development (Figure 2). We found a correlation between Chrdl1 upregulation in the
upper layers with that of GLUA2, consistent with our previous findings regarding Chrdl1 regulation
of GLUA2 levels (Blanco-Suarez et al., 2018). A more complex picture emerges for Gpc4, Gpc6, and
GLUA1, the AMPAR subunit regulated by these factors (Allen et al., 2012). GLUA1 protein levels
steadily increase across development, peaking in most layers at P7, and do not show downregulation
at P14 in L1 (as was observed for Gpc4), or upregulation in deeper layers (as was shown for Gpc6).
Still, changes in Gpc4 expression are contributing to the levels of GLUA1, as GLUA1 is affected in
correlation with changes in Gpc4 expression in the neuronal and astrocyte activity-deficit models
(Figures 4 and 5), and GLUA1 levels are reduced in the VC of Gpc4 KO mice (Farhy-Tselnicker
et al., 2017). One possibility is that Gpc4 and Gpc6 may regulate GLUA1 levels at specific synapses,
such as glutamatergic terminals onto interneurons in L1, or deep layer cortical neurons, making it
hard to distinguish their specific effect when analyzing synapses as a group. Alternatively, they may
be required to induce initial recruitment of GLUA1 to synaptic sites, but not for its maintenance, so
GLUA1 levels remain stable when Gpc4 is downregulated with development.

Neuronal and astrocyte activity modulate transcriptomic changes in
astrocytes
Ever since the astrocyte-
derived factors that promote synapse formation were identified, an
outstanding question in the field has been, how are they regulated (Baldwin and Eroglu, 2017;
Farhy-Tselnicker and Allen, 2018)? Is it astrocyte-intrinsic, or is it driven by changes in neuronal
activity that occur as synapses develop? Our in vitro work, together with previously published
studies, has provided evidence that neuronal activity can influence astrocyte gene expression and
function at the synapse (Figure 4—figure supplement 1, Benediktsson et al., 2012; Bernardinelli et al., 2014b; Durkee and Araque, 2019; Hasel et al., 2017). However, how this occurs in
the developing brain in vivo has not been systematically addressed. Here, we approached this
question by perturbing the activity of thalamocortical projections (through VGlut2 knockout), with
a goal of manipulating signals that have the potential to regulate astrocytic developmental gene
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expression under physiological conditions. Indeed, this perturbation resulted in attenuation of
the developmental expression changes in astrocyte genes as well as AMPAR subunits at P14 but
not at P7, suggesting a disruption in circuit maturation. A similar outcome on neuronal and astrocyte maturation was observed in studies employing visual deprivation methods (Albanese et al.,
1983; Desai et al., 2002; Freire, 1978; Funahashi et al., 2013; Ishikawa et al., 2014; Ko et al.,
2014; Müller, 1990; Stogsdill et al., 2017). Future strategies including manipulation of neuronal
and astrocyte function using opto- or chemogenetic approaches will further elucidate the role of
astrocyte-neuron interaction in circuit development and maturation.
An additional important regulation of astrocyte gene expression (including Gpc4 and Chrdl1)
revealed here is by IP3R2-mediated astrocyte calcium activity, a central mechanism for astrocytic
somal calcium increases, and as such, a likely candidate to modulate gene expression changes
(Petravicz et al., 2014; Srinivasan et al., 2015; Yu et al., 2020). Interestingly, blunting store-
mediated astrocytic calcium release (through Ip3r2 knockout) resulted in an opposite regulation
of gene expression to the ones observed in the VGlut2 cKO mice and did not correspond to layer-
specific developmental changes, suggesting a more global role of astrocyte calcium activity in the
regulation of gene expression. This is likely due to the overall diminished signaling that occurs in
this knockout model in response to multiple neurotransmitters that rely on calcium increases, and
in future, systematic deletion of individual receptors will be necessary to tease out the impact of
each neurotransmitter on astrocyte gene expression and synapse regulation. Notably, while we
observed significant effects on Gpc4 and Chrdl1 mRNA levels, Gpc6 expression was unaltered
in Ip3r2 KO VC at P14, suggesting distinct regulation of expression of the two glypican family
members, and synapse-modulating genes in general. The mechanisms underlying these effects
are unknown and likely involve activation of Ca2+-dependent cellular cascades and transcription
factors. Indeed, several such genes were identified in our snRNAseq dataset including Mapk10
and Pde4b, and will form the focus of future studies. Previous work in the adult striatum found that
increasing astrocytic calcium through activation of exogenous Gi-GPCRs using DREADDs induces
transient synapse formation by regulating expression of thrombospondin 1, with no effect on
Gpc4 or Chrdl1 (Nagai et al., 2019), suggesting specific dependence of age, region, and environmental cues on types of genes regulated by calcium activity. Furthermore, in addition to altered
gene expression in astrocytes, we observed diminished levels of presynaptic markers VGLUT1
and VGLUT2 in Ip3r2 KO mice, suggesting that in addition to having intrinsic roles in regulating
astrocytic gene expression IP3R2-mediated activity has a non-cell-autonomous effect on nearby
neurons. These data may suggest that behavioral deficits observed in Ip3r2 KO mice could
stem from the developmental alterations in synaptogenesis caused by lack of astrocyte calcium
responses. Importantly, the activity-mediated regulation of astrocytic gene expression observed
here appears to extend beyond synapse development as DEGs identified in the snRNAseq analysis of VGlut2 cKO and Ip3r2 KO mice span multiple cellular processes, including signal transduction, metabolism, and gene regulation (Figure 6—figure supplement 3A–C, Figure 6—source
data 1G). Many of these genes may potentially be involved in regulating synapses, and further
studies are required to characterize the most promising candidate genes identified here (such
as Sltm, Gm47283). This will help to determine the precise role of thalamocortical and astrocytic
calcium-dependent transcriptomic changes in regulating the different aspects of both astrocyte
and synapse function.
In all, this study demonstrates that the correct formation of synapses and hence neuronal circuit
connectivity depends on precise communication between neurons and astrocytes, where disruption
in one cell type leads to disruption in the other and an overall dysregulation of synapse formation.
It further shows that astrocyte regulation of synapses is intimately linked to environmental changes.
Thus, an image of astrocyte identity emerges as highly plastic and dynamic cells, actively perceiving
and responding to their environment. Future studies employing functional approaches such as electrophysiology, optogenetic manipulations, and behavior are needed to determine the precise nature
of astrocyte plasticity and to further distinguish intrinsic and extrinsic influences on these cells, giving
further insight into their function in both health and disease.

Key resources table

Materials and methods
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Reagent type (species)
or resource

Designation

Source or reference

Identifiers

Additional
information

Antibody

Anti-HA tag
(rat monoclonal)

Roche

CAT# 11867423001;
RRID:AB_390918

IF (1:1000)

Antibody

Anti-HA tag
(rabbit monoclonal)

CST

CAT# 3724;
RRID:AB_1549585

RiboTag pulldown
(1:200)
IF (1:500)

Antibody

Anti-NeuN
(mouse monoclonal)

Millipore

CAT# MAB377;
RRID:AB_2298772

IF (1:100)

Antibody

Anti-S100β
(rabbit polyclonal)

Abcam

CAT# ab52642;
RRID:AB_882426

IF (1:100)

Antibody

Anti-Ng2
(rabbit polyclonal)

Millipore

CAT# Ab5320;
RRID:AB_11213678

IF (1:200)

Antibody

Anti-MOG
(rabbit polyclonal)

Proteintech

CAT# 12690-1-ap;
RRID:AB_2145527

IF (1:200)

Antibody

Anti-Iba1
(rabbit polyclonal)

Wako

CAT# 016-20001;
RRID:AB_839506

IF (1:250)

Antibody

Anti-Sox9
(rabbit monoclonal)

Abcam

CAT# ab185966;
RRID:AB_2728660

IF (1:2000)

Antibody

Anti-Aldh1l1
(rabbit polyclonal)

Abcam

CAT# ab-87117;
RRID:AB_10712968

IF (1:500)

Antibody

Anti-glypican 4
(rabbit polyclonal)

Proteintech

CAT# 13048-1-AP;
RRID:AB_10640157

WB (1:500)

Antibody

Anti-IP3R2
(rabbit polyclonal)

Ju Chen lab UCSD

N/A

WB (1:1000)

Antibody

Anti-β-tubulin
(mouse monoclonal)

Thermo

CAT# MA5-16308;
RRID:AB_2537819

WB (1:5000)

Antibody

Anti-Bassoon
(mouse monoclonal)

Enzo

CAT# VAM-PS003;
RRID:AB_2066982

IF (1:500)

Antibody

Anti-VGLUT1
(guinea pig polyclonal)

Millipore

CAT# AB5905;
RRID:AB_2301751

IF (1:2000)

Antibody

Anti-VGLUT2
(guinea pig polyclonal)

Millipore

CAT# AB2251;
RRID:AB_2665454

IF (1:3000–5000)

Antibody

Anti-GLUA1
(rabbit polyclonal)

Millipore

CAT# AB1504;
RRID:AB_2113602

IF (1:400)

Antibody

Anti-GLUA2
(rabbit polyclonal)

Millipore

CAT# AB1768-I;
RRID:AB_2313802

IF (1:400)

Antibody

Anti-Neun-Alexa-488
(mouse monoclonal)

Millipore

CAT# MAB377X;
RRID:AB_2149209

FACS
(1:1000)

Antibody

Anti-GFP
(chicken polyclonal)

Millipore

CAT# 06-896;
RRID:AB_11214044

IF (1:500)

Antibody

Anti-rat Alexa-488
(goat polyclonal)

Molecular Probes

CAT# A11006;
RRID:AB_141373

IF (1:500)

Antibody

Anti-rat Alexa-594
(goat polyclonal)

Molecular probes

CAT# A11007;
RRID:AB_141374

IF (1:500)

Antibody

Anti-mouse Alexa-488
(goat polyclonal)

Molecular Probes

CAT# A11029;
RRID:AB_138404

IF (1:500)

Antibody

Anti-mouse Alexa-594
(goat polyclonal)

Molecular Probes

CAT# A11032;
RRID:AB_141672

IF (1:500)

Antibody

Anti-mouse Alexa-680
(goat polyclonal)

Molecular Probes

CAT# A21057;
RRID:AB_141436

WB (1:10,000)

Antibody

Anti-rabbit Alexa-488
(goat polyclonal)

Molecular Probes

CAT# A11034;
RRID:AB_2576217

IF (1:500)
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Antibody

Anti-rabbit Alexa-594
(goat polyclonal)

Molecular Probes

CAT# A11037;
RRID:AB_2534095

IF (1:500)

Antibody

Anti-rabbit Alexa-647
(goat polyclonal)

Molecular Probes

CAT# A21245;
RRID:AB_2535813

IF (1:500)

Antibody

Anti-rabbit Alexa-680
(goat polyclonal)

Molecular Probes

CAT# A21109;
RRID:AB_2535758

WB (1:10,000)

Antibody

Anti-guinea pig Alexa-488
(goat polyclonal)

Molecular Probes

CAT# A11073;
RRID:AB_142018

IF (1:500)

Antibody

Anti-guinea pig Alexa-594
(goat polyclonal)

Molecular Probes

CAT# A11076;
RRID:AB_141930

IF (1:500)

Antibody

Anti-guinea pig Alexa-647
(goat polyclonal)

Molecular Probes

CAT# A21450;
RRID:AB_141882

IF (1:500)

Antibody

Anti-chicken Alexa-488
(goat polyclonal)

Molecular Probes

CAT# A11039;
RRID:AB_142924

IF (1:500)

Chemical compound, drug Papain

Worthington

CAT# PAP2 3176

 

Chemical compound, drug Trypsin inhibitor

Worthington

CAT# LS003086

 

Chemical compound, drug Isolectin

Vector

CAT# L-1100

 

Chemical compound, drug Trypsin

Sigma

CAT# T9935

 

Chemical compound, drug Poly-D-lysine

Sigma

CAT# P6407

 

Chemical compound, drug Laminin

Cultrex Trevigen

CAT# 3400-010-01

 

Chemical compound, drug N-acetyl-L-cysteine

Sigma

CAT# A8199

 

Chemical compound, drug Insulin

Sigma

CAT# I1882

 

Chemical compound, drug Triiodo-thyronine

Sigma

CAT# T6397

 

Chemical compound, drug Transferrin

Sigma

CAT# T1147

 

Chemical compound, drug BSA

Sigma

CAT# A4161

 

Chemical compound, drug Progesterone

Sigma

CAT# P6149

 

Chemical compound, drug Putrescine

Sigma

CAT# P5780

 

Chemical compound, drug Sodium selenite

Sigma

CAT# S9133

 

Chemical compound, drug Forskolin

Sigma

CAT# F6886

 

Chemical compound, drug FUDR

Sigma

CAT# F0503

 

Chemical compound, drug AraC

Sigma

CAT# C1768

 

Chemical compound, drug Hydrocortisone

Sigma

CAT# H0888

 

Chemical compound, drug B27/NS21

Winzeler and Wang,
2013

N/A

 

Peptide, recombinant
protein

BDNF

PeproTech

CAT# 450-02

 

Peptide, recombinant
protein

CNTF

PeproTech

CAT# 450-13

 

Chemical compound, drug Complete Protease Inhibitor Cocktail

Sigma

CAT# 04693132001

 

Chemical compound

Sigma

CAT# L5501

 

Chemical compound, drug SlowFade Gold with DAPI mounting media

Thermo Fisher

CAT# S36939

 

Chemical compound, drug DAPI

Millipore

CAT# 5.08741.0001

 

Chemical compound, drug Ketamine

Victor Medical
Company

N/A

 

L-lysine

Farhy-Tselnicker et al. eLife 2021;10:e70514. DOI: https://doi.org/10.7554/eLife.70514



25 of 43

Developmental Biology | Neuroscience

Research article
Reagent type (species)
or resource

Source or reference

Identifiers

Additional
information

Chemical compound, drug Xylazine

Anased

N/A

 

Peptide, recombinant
protein

Promega

CAT# N2115

 

Chemical compound, drug Heparin

Sigma

CAT# H3393

 

Chemical compound, drug Protease Inhibitor Cocktail

Sigma

CAT# P8340

 

Peptide, recombinant
protein

RNaseOUT Recombinant Ribonuclease
Inhibitor

Thermo Fisher

CAT# 10777019

 

Peptide, recombinant
protein

SUPERase• In RNase Inhibitor

Thermo Fisher

CAT# AM2694

 

Chemical compound, drug OptiPrep

Sigma

CAT# D1556

 

Chemical compound, drug Hoechst 33342

Thermo Fisher

CAT# 62249

 

Other

Thermo Fisher

CAT# 88847

 

Chemical compound, drug Cycloheximide

Sigma

CAT# C7698

 

Chemical compound, drug UltraPure BSA

Thermo Fisher

CAT# AM2618

 

Commercial assay or kit

Bradford assay

Bio-Rad

CAT# 5000203

 

Commercial assay or kit

RNeasy mini kit

Qiagen

CAT# 74104

 

Commercial assay or kit

RNAeasy plus micro kit

Qiagen

CAT# 74034

 

Commercial assay or kit

RNAscope 2.5 HD—multiplex fluorescent
Manual Assay

ACDbio

CAT# 320850

 

Commercial assay or kit

Qbit

Thermo Fisher

CAT# Q33238

 

Commercial assay or kit

TapeStation

Agilent

CAT# G2991AA

 

Commercial assay or kit

TruSeq Stranded mRNA Library Preparation Kit Illumina

CAT# RS-122-2101

 

Commercial assay or kit

10X Chromium 3′ kit V3

10X Genomics

CAT# PN-1000073

 

Cell line
(mouse)

T11D7e2 Hybridoma

ATCC

CAT# TIB-103; RRID:CVCL_
F769
 

Genetic reagent (mouse)

Tg(Aldh1l1-EGFP)OFC789Gsat/Mmucd

UC Davis

011015-UCD;
RRID:MMRRC_011015-UCD  

Genetic reagent (mouse)

B6N.129-Rpl22tm1.1Psam/J

Jackson Labs

Jax # 011029; RRID:IMSR_
JAX:011029

 

Genetic reagent (mouse)

B6.Cg-Tg(Gfap-cre)73.12Mvs/J

Jackson Labs

Jax# 012886; RRID:IMSR_
JAX:012886

 

Genetic reagent (mouse)

B6.C-Gt(ROSA)26Sortm14(CAG-tdTomato)

Jackson Labs

Jax # 007914; RRID: IMSR_
JAX:007914

 

Genetic reagent (mouse)

Slc17a6tm1Lowl/J

Jackson Labs

Jax # 12898; RRID:IMSR_
JAX:012898

 

Genetic reagent (mouse)

Designation

RNAsin

Magnetic IgG beads

Roratm1(cre)Ddmo

O’Leary lab
(Salk Institute)
Chou et al., 2013

MGI:5000017

Chen lab (UCSD)
Li et al., 2005

Genetic reagent (mouse)

Itpr2tm1.1Chen

Sequence-based reagent

RNAscope probe: 3-plex negative control

ACDbio

CAT# 320871

 

Sequence-based reagent

RNAscope probe: Gpc4

ACDbio

CAT# 442821

 

Sequence-based reagent

RNAscope probe: Gpc5

ACDbio

CAT# 442831

 

Sequence-based reagent

RNAscope probe: Gpc6-01

ACDbio

CAT# 453301

 

Farhy-Tselnicker et al. eLife 2021;10:e70514. DOI: https://doi.org/10.7554/eLife.70514

MGI:3640970



26 of 43

Developmental Biology | Neuroscience

Research article
Reagent type (species)
or resource

Designation

Source or reference

Identifiers

Additional
information

Sequence-based reagent

RNAscope probe: Chrdl1

ACDbio

CAT# 442811

 

Sequence-based reagent

RNAscope probe: Thbs1

ACDbio

CAT# 457891

 

Sequence-based reagent

RNAscope probe: Thbs2

ACDbio

CAT# 492681

 

Sequence-based reagent

RNAscope probe: Thbs4

ACDbio

CAT# 526821

 

Sequence-based reagent

RNAscope probe: Slc1a3 (Glast) channel 2

ACDbio

CAT# 430781-C2

 

Sequence-based reagent

RNAscope probe: Tubb3 channel 3

ACDbio

CAT# 423398-C3

 

Software, algorithm

Imaris

Bitplane

RRID:SCR_007370

 

Software, algorithm

ImageJ (Fiji)

NIH

RRID:SCR_003070

 

Software, algorithm

Zen

Zeiss

RRID:SCR_013672

 

Software, algorithm

AxioVision

Zeiss

RRID:SCR_002677

 

Software, algorithm

Odyssey Image Studio

LI-COR

RRID:SCR_014211

 

Software, algorithm

InteractiVenn

Heberle et al., 2015

N/A

 

Software, algorithm

GraphPad Prism

Prism

RRID:SCR_002798

 

Software, algorithm

Python

 

RRID:SCR_008394

 

Software, algorithm

RStudio

 

RRID:SCR_000036

 

Other

Cell culture inserts

Thermo Fisher

CAT# 353102

 

Other

Vivaspin centrifugal concentrator

Sartorius

CAT# 14558502

 

Other

4–12% bolt gels

Thermo Fisher

CAT# NW04120

 

Other

PVDF membranes, Immobilon-FL

Millipore

CAT# IPFL00005

 

Other

Odyssey Infrared Imager

LI-COR

N/A

 

Other

Fluorescence microscope with apotome

Zeiss

Axio Imager.Z2

 

Other

Cryostat

Hacker Industries

OTF5000

 

Other

Confocal microscope

Zeiss

LSM710

 

Other

Confocal microscope

Zeiss

LSM880

 

Other

FACS Aria Fusion sorter

BD

N/A

 

Other

HybEZ hybridization system

ACDbio

N/A

 

Other

Illumina HiSeq 2500

Illumina

N/A

 

Other

NovaSeq 6000

Illumina

N/A

 

Contact for reagent and resource sharing
Further information and requests for resources and reagents should be directed to and will be fulfilled
by the lead contact, Nicola J. Allen (nallen@salk.edu).

Animals
All animal work was approved by the Salk Institute Institutional Animal Care and Use Committee.

Rats
Sprague–Dawley rats (Charles Rivers) were maintained in the Salk Institute animal facility under a 12 hr
light:dark cycle with ad libitum access to food and water. Rat pups (both male and female) were used
at P1–2 for preparation of primary cortical astrocyte cultures, and at P5–P7 for preparation of purified
immunopanned retinal ganglion cell (RGC) neuronal cultures.
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Mice
Mice were maintained in the Salk Institute animal facility under a 12 hr light:dark cycle with ad libitum
access to food and water. Both male and female mice were used for experiments.
The following mouse lines were used:
1. Wild-type (WT; C57Bl6/J) were purchased from Jackson Labs and bred in-house (Jax #000664).
Mice were used for breeding and backcrossing, and as non-littermate controls.
2. RiboTag floxed (B6N.129-Rpl22tm1.1Psam/J) were obtained from Jackson Labs (Jax #011029).
Mice were maintained as homozygous for floxed Rpl22 on C57Bl6/J background and crossed
to mice expressing cre recombinase for experiments.
Gfap-cre (B6.Cg-Tg (Gfap-cre)73.12Mvs/J) mice were obtained from Jackson Labs (Jax #012886)
and bred in-house to generate cre+ females.
To generate Astrocyte-
RiboTag mice, homozygous flox-
Rpl22-
HA males were crossed to
Gfap-
cre hemizygous females. Male mice hemizygous for cre and heterozygous for flox-
Rpl22-HA (Rpl22-HA+; Gfapcre+) were used for all experiments.
3. Aldh1l1-GFP (Tg(Aldh1l1-EGFP)OFC789Gsat/Mmucd) were obtained from MMRRC. They were backcrossed to C57Bl6/J background (Jax #000664) for at least four generations prior to conducting
experiments.
4. VGlut2 floxed (Slc17a6tm1Lowl/J) were obtained from Jackson Labs (Jax #012898). Mice were
maintained as homozygous for floxed VGlut2 on a C57Bl6/J background and crossed to mice
expressing cre recombinase for experiments.
RORα-IRES-Cre (Roratm1(cre)Ddmo) were obtained from Dennis O’Leary at the Salk Institute and
described in Chou et al., 2013 and Farhy-Tselnicker et al., 2017. Mice were maintained on the
C57Bl6/J (Jax #000664) background and crossed to the VGlut2 flox and/or tdTomato reporter
(B6.Cg-Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/J (Ai14; Jax #007914)) lines for experiments.
To generate conditional VGlut2 KO mice, Slc17a6f/f females were bred to Slc17a6f/f;RORαcre+-
positive males. Slc17a6f/f;RORαcre+ (cre-
positive) littermates were compared with Slc17a6f/
f
cre;RORα (cre-negative) in each experiment.
To generate het and homozygous VGlut2 cKO mice expressing tdTomato in the recombined
neurons (Figure 4, Figure 4—figure supplement 2), Slc17a6f/+;RORαcre+;Rosa26tdTomato+ males
were crossed to Slc17a6f/f females. As control in these experiments, RORαcre+ mice were crossed
to Rosa26tdTomato+, generating Slc17a6+/+;RORαcre+Rosa26tdTomato+ mice.
5. Ip3r2 KO (Itpr2tm1.1Chen) was obtained from Ju Chen lab at UCSD (Li et al., 2005) and maintained on C57BL6/J background, either as KO × KO breeding scheme, or het × het breeding
scheme. Both littermate and non-littermate pairs of WT and KO mice were used for experiments. For non-littermate pairs, C57Bl6/J that were bred in-house were used as control.
In all cases, when littermates could not be used as control, mice were matched by age, size, fur
color and condition, and eye opening to ensure identical developmental stage.

Mouse tissue collection
Tissue was collected at the following developmental time points: P1, P4, P7, P14, P21, P28, and
P120.

RiboTag RNAseq
All mice were collected between 9:30 am and 12:30 pm on the day of experiment. Mice were anesthetized by I.P. injection of 100 mg/kg ketamine (Victor Medical Company)/20 mg/kg xylazine (Anased)
mix, and transcardially perfused with 10 ml PBS then 10 ml 1% PFA. Brains were dissected in 2.5 mM
HEPES-KOH pH 7.4, 35 mM glucose, 4 mM NaHCO3 in 1× Hank’s Balanced Salt Solution with 100 µg/
ml cycloheximide added fresh (Heiman et al., 2014). Brains were cut at approximately bregma –2.4
to isolate the VC, the cortex was carefully detached from the subcortical areas, and any visible white
matter was removed. Lateral cuts were made at 1 mm and 3 mm from the midline to further isolate
the VC section, and RiboTag pulldown was immediately performed. For each time point, the visual
cortices from mice (Rpl22-HA+; Gfap cre+) were pooled for RNA isolation and RNA sequencing library
preparation. P7 = 3 biological replicates (6 mice , 2 × 3); P14 = 4 biological replicates (8 mice, 2 × 4);
P28 = 5 biological replicates (10 mice, 2 × 5); P120 = 6 biological replicates, 3 new samples (6 mice,
2 × 3), plus for data analysis 3 additional P120 biological replicates from a previously published study
from the lab (Boisvert et al., 2018; GEO GSE99791), collected and processed in the same way, were
included to increase the power of the analysis.
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Histology (smFISH in situ hybridization and immunostaining)
Mice aged P4 and older were anesthetized by I.P. injection of 100 mg/kg ketamine (Victor Medical
Company)/20 mg/kg xylazine (Anased) mix and transcardially perfused with PBS, then 4% PFA at
room temperature. Brains were removed and incubated in 4% PFA overnight at 4 C, then washed
3 × 5 min with PBS, and cryoprotected in 30% sucrose for 2–3 days, before being embedded in
TFM media (General Data Healthcare #TFM-5), frozen in dry ice-ethanol slurry solution, and stored
at –80° C until use. P1 mice were decapitated and brains removed without perfusion, briefly washed
in PBS and placed in 4% PFA overnight at 4° C, followed by a similar procedure as described above
for older mice. Brains were sectioned using a cryostat (Hacker Industries #OTF5000) in sagittal or
coronal orientations depending on experimental needs at a slice thickness of 16–25 µm. Sections
were mounted on Superfrost Plus slides (Fisher #1255015). Immunostaining for synaptic markers and
smFISH was performed on the same day of sectioning. 3–5 mice were used for each experimental
group. For each mouse, three sections were imaged and analyzed.

Single-nucleus RNAseq and western blot
Mice were anesthetized by I.P. injection of 100 mg/kg ketamine (Victor Medical Company)/20 mg/
kg xylazine (Anased) mix, then decapitated. Brains were rapidly removed and the VC dissected in
ice-cold PBS using the same coordinates as described for RiboTag RNAseq. Dissected cortices were
snap frozen, and kept at –80° C until use. For snRNAseq, 4 mice were collected for each experimental
group. For western blot, 2–4 independent experiments/samples for each condition were analyzed.

RNAseq
Bulk RNAseq using RiboTag
RiboTag pulldown
A modified RiboTag protocol was performed to isolate astrocyte-
enriched RNA. Briefly, brain
samples were homogenized using a Dounce homogenizer (Sigma #D9063) in 2 ml cycloheximide-
supplemented homogenization buffer (1% NP-40, 0.1 M KCl, 0.05 M Tris, pH 7.4, 0.012 M MgCl2 in
RNase-free water, with 1:1000 1 M DTT, 1 mg/ml heparin, 0.1 mg/ml cycloheximide, 1:100 protease
inhibitors, and 1:200 RNAsin added fresh). Homogenates were centrifuged and the supernatant incubated on a rotator at 4°C for 4 hr with 5 μl anti-HA antibody to bind the HA-tagged ribosomes (CST
Rb anti-HA #3724, 1:200). Magnetic IgG beads (Thermo Scientific Pierce #88847) were conjugated to
the antibody-ribosome complex via overnight incubation on a rotator at 4°C. Samples were washed
with a high salt buffer (0.333 M KCl, 1% NP40, 1:2000 1 M DTT, 0.1 mg/ml cycloheximide, 0.05 M Tris
pH 7.4, 0.012 M MgCl2 in RNase-free water), and RNA released from ribosomes with 350 μl RLT buffer
(from Qiagen RNeasy kit) with 1% BME. RNA was purified using RNeasy Plus Micro kit (Qiagen 74034)
according to the manufacturer’s instructions and eluted into 16 μl RNase-free water. Eluted RNA was
stored at –80 °C. For each time point, 50 μl of homogenate (pre-anti-HA antibody addition) was set
aside after centrifugation, kept at –20 °C overnight, and purified via RNeasy Micro kit as an ‘input’
sample, and used to determine astrocyte enrichment.

Library generation and sequencing
RNA quantity and quality were measured with a Tape Station (Agilent) and Qubit Fluorimeter (Thermo
Fisher) before library preparation. >100 ng of RNA was used to make libraries. mRNA was extracted
with oligo-dT beads, capturing polyA tails, and cDNA libraries made with Illumina TruSeq Stranded
mRNA Library Preparation Kit (RS-122-2101) by the Salk Institute Next Generation Sequencing (NGS)
Core. Samples were sequenced on an Illumina HiSeq 2500 with single-end 50 base-pair reads, at
12–70 million reads per sample.

RNA sequencing mapping, analysis, and statistics
Raw sequencing data was demultiplexed and converted into FASTQ files using CASAVA (v1.8.2)
and quality tested with FASTQC v0.11.2. Alignment to the mm10 genome was performed using the
STAR aligner version 2.5.1b (Dobin et al., 2013). Mapping was carried out using default parameters
(up to 10 mismatches per read, and up to 9 multi-mapping locations per read), and a high ratio of
uniquely mapped reads (>75%) was confirmed with exonic alignment inspected to ensure that reads
were mapped predominantly to annotated exons. Raw and normalized (FPKM) gene expression was
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quantified across all genes (RNAseq) using the top-expressed isoform as a proxy for gene expression using HOMER v4.10 (Heinz et al., 2010), resulting in 10–55 million uniquely mapped reads in
exons. Principal component analysis was carried out with prcomp in R 3.4.3 on normalized counts.
Differential gene expression was carried out using the DESeq2 (Love et al., 2014) package version
1.14.1 using the HOMER g
 etDiffExpression.pl script with default normalization and using replicates
to compute within-group dispersion. Significance for differential expression was defined as adjusted
p<0.05 (also labeled as FDR), calculated using Benjamini–Hochberg’s procedure for multiple comparison adjustment.
Significantly altered genes are presented in three categories:
All genes: FPKM >1, adjusted p<0.05.
Astrocyte-expressed genes: RiboTag pulldown (astrocyte)/input (all cells) > 0.75, FPKM > 1,
adjusted p<0.05.
Astrocyte-enriched genes: RiboTag pulldown (astrocyte)/input (all cells) > 3, FPKM > 1, adjusted
p<0.05.
See also Boisvert et al., 2018. A full list of genes in each time point is presented in Figure 1—
source data 1A.

GO enrichment analysis
GO terms that are enriched in astrocytes at each developmental stage were identified using the
String database (https://string-db.org/)(Szklarczyk et al., 2019). A search using multiple proteins by
gene name was performed with the default parameters, and GO BP category selected and exported
from the analysis tab. GO terms with gene ratio of 0.5 and above were selected, and plotted for
each age group, with x-axis showing the ratio of genes overlapping with each GO term, and bar fill
color is the significance of the overlap (adj. p-value; FDR). GO terms common to all age groups were
obtained using the Venn diagram (http://www.interactivenn.net/; Heberle et al., 2015), and terms
with gene ratio equal to or above 0.5 were selected and plotted. A full list of GO terms is presented
in Figure 1—source data 1B.

Single-nucleus RNAseq
Sample preparation
A total of 8 samples (two for VGlut2 WT, two for VGlut2 cKO, two for Ip3r2 WT, two for Ip3r2 KO) were
sequenced to obtain the dataset described in Figure 6, Figure 6—figure supplement 1, Figure 6—
figure supplement 2. The samples were as follows: VGlut2 WT_1; VGlut2 cKO_1; VGlut2 WT_2;
VGlut2 cKO_2; Ip3r2 WT_1; Ip3r2 KO_1; Ip3r2 WT_2; Ip3r2 KO_2. Each group consisted of one replicate from male mice and one replicate from female mice. Each replicate consisted of the VC from
both hemispheres of two mice of the same genotype and gender. Nuclear isolation, FACS sorting,
10× barcoding, and cDNA preparation were performed on the same day using WT and KO pair,
which were processed in parallel, resulting in four separate procedures. cDNA was stored at –20°C
until all samples were collected. Library preparation and sequencing were carried out at the same time
for all eight samples.

Nuclei preparation
Nuclei were isolated from frozen VC tissue. Tissue was manually homogenized using a two-step
Dounce homogenizer (A and B) (Sigma #D9063) in NIMT buffer, containing (in mM: 250 sucrose, 25
KCl, 5 MgCl2, 10 Tris-Cl pH 8, 1 DTT; 1:100 dilution of Triton X100, Protease Inhibitor Cocktail [Sigma
#P8340]; and 1:1000 dilution of RNaseOUT Recombinant Ribonuclease Inhibitor [Thermo #10777019];
SUPERase• In RNase Inhibitor [Thermo #AM2694]) on ice. Homogenized samples were mixed with
50% iodixanol (OptiPrep Density Gradient Medium; Sigma #D1556) and loaded onto 25% iodixanol
cushion, and centrifuged at 10,000 g for 20 min at 4°C in a swinging bucket rotor (Sorval HS-4). Pellets
resuspended in ice-cold DPBS (HyClone) with 1:1000 dilution of RNaseOUT Recombinant Ribonuclease Inhibitor (Thermo #10777019); SUPERase• In RNase Inhibitor (Thermo #AM2694). Nuclei were
then incubated for 7 min on ice with Hoechst 33342 solution (20 mM) (Thermo #62249) (final concentration 0.5 µM), followed by centrifugation at 1000 g for 10 min at 4° C to pellet nuclei. Pellets were
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resuspended in blocking buffer containing DPBS with RNAse inhibitors, and 1:10 dilution of pure
BSA, and blocked for 30 min on ice. NEUN-Alexa488 pre-conjugated antibody (Millipore #MAB377X)
was then added at 1:1000 dilution and incubated for at least 1 hr on ice before proceeding to flow
cytometry sorting.

Flow cytometry
Fluorescence-activated nuclei sorting (FANS) was performed in the Salk Institute Flow Cytometry core
using a BD FACS Aria Fusion sorter with PBS for sheath fluid (a 100 μm nozzle was used for these
experiments with sheath pressure set to 20 PSI). Hoechst-positive nuclei were gated first (fluorescence
measured in the BV421 channel), followed by exclusion of debris using forward and side scatter pulse
area parameters (FSC-A and SSC-A), exclusion of aggregates using pulse width (FSC-W and SSC-W),
before gating populations based on NEUN fluorescence (using the FITC channel). To isolate the non-
neuronal cell population, nuclei devoid of FITC signal (NEUN-) were collected (Figure 6A). Nuclei
were purified using a one-drop single-cell sort mode (for counting accuracy); these were directly
deposited into a 1.5 ml Eppendorf without additional buffer (to yield a sufficient concentration that
permitted direct loading onto the 10× chip).
Sorted NeuN-negative nuclei were immediately processed with 10X Chromium kit (10X Genomics)
for single-nucleus barcoding. Nuclei were kept on ice for the entire process. At each time, WT and KO
samples were processed in parallel on the same day.

10X Chromium barcoding, library preparation, and sequencing
Single-nuclei separation, barcoding, and cDNA generation were performed following the manufacturer’s instruction using the Chromium single cell 3′ kit (V3, 10X Genomics PN-1000073). cDNA concentration and quality were measured using Qubit Fluorimeter (Thermo Fisher) and Tape Station (Agilent),
respectively, and was stored at –20° C until library preparation.
Libraries were generated from all samples at the same time (eight total samples, 2 WT/2 KO Vglut2
cKO model; 2 WT/2KO IP3R2 KO model) following the manufacturer’s instructions using the Chromium single cell 3′ kit (V3, 10X Genomics PN-1000075). Library quality was assessed with a Tape
station (Agilent). NovaSeq sequencing was performed at the UCSF Center for Advanced Technology,
at ~300 million reads/sample (60,000 reads/cell).

Single-cell RNAseq data preprocessing and clustering
Data was demultiplexed and mapped onto the mouse genome (mm10) using 10X Cellranger
(v3.1.0) with default parameters. Cell barcodes with <200 genes detected were discarded due to
low coverage. Doublets were identified and removed using Scrublet (Wolock et al., 2019) with its
default setting in each sample. The average number of UMIs per cell was 2310 ± 878; average number
of genes detected per cell (UMI ≥ 1) was 1168 ± 328. Cell clusters were identified using Scanpy
(v1.4.3), following the clustering process described in Luecken and Theis, 2019. All the samples
were combined and used the top 5000 highly variable genes as the input dimension reduction. To
identify clusters, Scanorama (v1.0.0, default parameter, k = 20; Hie et al., 2019) was used to perform
batch correction and dimension reduction (30 PCs), followed by Leiden clustering (Traag et al., 2019;
resolution = 1). Data was visualized using the UMAP embedding (McInnes et al., 2018) function from
Scanpy. The ensemble clustering identified all astrocytes as one cluster, and to further identify astrocytes subtypes, we repeated the same clustering process on the astrocytes cluster only and got four
subtypes. Astrocyte clusters were annotated using cell-type marker genes identified from previous
studies to label distinct cortical astrocyte populations (Bayraktar et al., 2020; Lanjakornsiripan
et al., 2018; Marques et al., 2016; Tasic et al., 2018; Van Hove et al., 2019 ; Zeisel et al., 2018). A
full list of genes in each layer group is presented in Figure 6—source data 1A and B.

Identifying DEGs
To identify cluster-specific DEGs, we used the scanpy.tl.rank_gene_groups function to perform the
Wilcoxon rank-sum test with Benjamini–Hochberg correction to compare cells from each cluster with
the remaining cells. Genes with FDR < 0.1 and log2 FC between –0.15 and 0.15 were identified
as DEGs. To identify DEGs between KO and WT, we performed the same analysis using combined
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astrocyte clusters. All comparisons were performed separately for VGlut2 cKO and Ip3r2 KO samples.
A full list of DEGs is presented in Figure 6—source data 1D.

GO enrichment analysis
GO terms that are enriched in astrocyte gene groups within each cluster, as well as genes regulated
by neuronal or astrocyte activity, were identified using the String database (https://string-db.org/)(
Szklarczyk et al., 2019). A search using multiple proteins by gene name was performed separately
on VGlut2 cKO and Ip3r2 KO samples, and up- and downregulated DEGs, using the default parameters, and GO BP category selected and exported from the “analysis“ tab. 20 GO terms with highest
gene ratio were selected and plotted for each model, with x-axis showing the ratio of genes overlapping with each GO term, and bar fill color is significance of the overlap (adj. p-value; FDR). GO
terms common to both models were obtained using the Venn diagram (http://www.interactivenn.net/;
Heberle et al., 2015) and plotted. A full list of GO terms is presented in Figure 6—source data 1C
and G.

Cell culture
RGC neuron purification and culture
RGC purification and culture was performed as described (Allen et al., 2012; Ullian et al., 2001;
Winzeler and Wang, 2013). Briefly, retinas from P5 to P7 rat pups of both sexes were removed
and placed in DPBS (HyClone #SH30264). Retinas were digested with Papain (Worthington #PAP2
3176; 50 units) for 30 min at 34°C , triturated with low OVO (15 mg/ml trypsin inhibitor; Worthington
#LS003086), then high OVO (30 mg/ml trypsin inhibitor; Worthington #LS003086) solutions. The cell
suspension was then added to lectin (Vector #L-1100)-coated Petri dishes to pull down microglia and
fibroblast cells for 5–10 min at room temperature. The remaining cells were then added to T11D7
hybridoma supernatant-coated Petri dishes for 40 min at room temperature, which specifically binds
RGCs. After washing off the non-binding cells with DPBS, pure RGCs were released by trypsin treatment (Sigma #T9935) to cleave cell-antibody bond and collected. RGCs were plated on six-well
plates coated with PDL (Sigma # P6407) and laminin (Cultrex Trevigen #3400-010-01) at a density of
125,000 cells/well. RGCs were maintained in the following media: 50% DMEM (LifeTech #11960044);
50% Neurobasal (LifeTech #21103049); Penicillin-
Streptomycin (LifeTech #15140-
122); glutamax
(LifeTech #35050-061); sodium pyruvate (LifeTech #11360-070); N-acetyl-L-cysteine (NAC) (Sigma
#A8199); insulin (Sigma #I1882); triiodo-
thyronine (Sigma #T6397); SATO (containing transferrin
[Sigma #T-1147]; BSA [Sigma #A-4161]; progesterone [Sigma #P6149]; putrescine [Sigma #P5780];
sodium selenite [Sigma #S9133]); and B27 (see Winzeler and Wang, 2013 for recipe). For complete
growth media, the media was supplemented with BDNF (PeproTech #450-02), CNTF (PeproTech
#450-13), and forskolin (Sigma #F6886). The next day, half of the media was replaced with media
containing FUDR (13 μg/μl final concentration; Sigma #F0503) to inhibit fibroblast growth. Cells
were fed by replacing half of the media with fresh equilibrated media every 3–4 days. RGCs were
maintained at 37° C/10% CO2 and kept in culture for at least 7 days prior to treatment to allow for
full process outgrowth.

Astrocyte preparation and culture
Primary astrocytes from rat cortex were prepared as described (Allen et al., 2012; McCarthy and de
Vellis, 1980). Briefly, the cerebral cortex from P1 to P2 rat pups were removed and placed in DPBS
(HyClone #SH30264). The meninges and hippocampi were removed and discarded. The remaining
cortices were diced and digested with Papain (Worthington #LS003126; 330 units) for 1 hr and 15 min
in 37° C 10% CO2 cell culture incubator. Cells were triturated in low OVO and then high OVO-
containing solutions, and plated in PDL-coated 75 cm tissue culture flasks. 3 days after plating, flasks
were manually shaken to remove upper cell layers, which contained mostly non-astrocytic cells. 2 days
after shake off, ARA-C (10 μM final concentration; Sigma #C1768) was added for 48 hr to inhibit the
other proliferating cells, which divide faster than astrocytes. Finally, astrocytes were plated in 15 cm
cell culture plates coated with PDL at 2–3 million cells/dish and passaged once a week. Astrocytes
were maintained at 37° C/10% CO2 and kept in culture for 3–4 weeks. Astrocyte culture medium was
DMEM (LifeTech #11960044) supplemented with 10% heat-inactivated FBS (LifeTech #10437028),
Penicillin-
Streptomycin (LifeTech #15140-
122), glutamax (LifeTech #35050-
061), Insulin (Sigma
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#I1882), sodium pyruvate (LifeTech #11360-070), hydrocortisone (Sigma #H0888), and N-acetyl-L-
cysteine (Sigma #A8199).

Treatment of astrocyte cultures with cultured neurons
Cultured astrocytes were plated on cell culture inserts (Falcon #353102) at 250,000 cells/insert. Inserts
were added to six-well plates containing either plated RGC neurons (at ~125,000 cells/well) or empty
wells coated with PDL and laminin (similar to RGC-plated wells) and containing media. Cells were incubated together for 4 days in low protein conditioning media containing (50% DMEM, 50% Neurobasal media; Penicillin-Streptomycin; glutamax and sodium pyruvate, NAC, BDNF, CNTF, forskolin),
after which conditioned media was collected and concentrated 50-fold using 10 kDa cutoff concentrators (Sartorius #14558502). Protein concentration was measured using the Bradford assay. Three
experimental groups were compared: RGCs alone, astrocytes alone, and astrocytes + RGCs.

Treatment of astrocyte cultures with neurotransmitters
Astrocytes were plated on six-well plates at 150,000 cell/well and allowed to reach 90% confluency
(1–2 days). Then astrocytes were incubated for 48 hr in low protein medium containing (50% DMEM,
50% Neurobasal media; Penicillin-Streptomycin; glutamax and sodium pyruvate) alone (control),
or with either 100 μM glutamate (Sigma #G5889-
100G), 10 μM adenosine (Sigma #A4036-
5G),
or 100 μM ATP (Sigma #A6419-1G) final concentration. Conditioned media was then collected as
described above. Concentration was measured with Bradford assay. Samples were stored at 4° C for
up to 7 days or processed immediately for western blot.

Western blot
Samples were heated in reducing loading dye (Thermo # 39000) for 45 min at 55° C. For conditioned
media, 10 µg/well was loaded; for tissue lysates, 20 µg/lane was loaded. Samples were resolved on
4–12% bis-tris or bolt gels (Invitrogen #NW04120) for 30–40 min at 150–200 V. Proteins were transferred to PVDF membranes at 100 V for 1 hr, then blocked in 1 % casein (Bio-Rad #1610782) in TBS
(Bioworld #105300272) blocking buffer for 1 hr at room temperature on a shaker. Primary antibodies
were applied overnight at 4° C diluted in blocking buffer. The antibodies used were Rb anti-glypican
4 (Proteintech #13048-1-AP; 1:500), Rb anti-IP3R2 (a gift from Ju Chen lab, UCSD 1:1000), and Ms
anti-tubulin (Thermo #MA5-16308 1:5000). The next day, membranes were washed 3 × 10 min with
TBS-0.1% Tween and the appropriate secondary antibody conjugated to Alexa Fluor 680 (Molecular
Probes) was applied for 2 hr at room temperature (dilution 1:10,000). Bands were visualized using
the Odyssey Infrared Imager (LI-COR) and band intensity analyzed using the Image Studio software
(LI-COR).

Histology
Immunostaining in mouse brain tissue
The slides containing the sections were blocked for 1 hr at room temperature in blocking buffer
containing antibody buffer (100 mM L-lysine and 0.3% Triton X-100 in PBS) supplemented with 10%
heat-inactivated normal goat serum. Primary antibodies diluted in antibody buffer with 5% goat
serum were incubated overnight at 4° C. The next day, slides were washed 3 × 5 min with PBS with
0.2% Triton X-100 and secondary antibodies conjugated to Alexa Fluor (Molecular Probes) were
applied for 2 hr at room temperature. Slides were mounted with the SlowFade Gold with DAPI
mounting media (LifeTech #S36939), covered with 1.5 glass coverslip (Fisher #12544E) and sealed
with clear nail polish. The following antibodies were used: Chk anti-GFP (Millipore #06-896, 1:500),
Rb anti-SOX9 (Abcam #ab185966, 1:2000), Rb anti-ALDH1L1 (Abcam #ab-87117, 1:500), Rb anti-HA
(CST #3724), Rb anti-S100β (Abcam #ab52642, 1:100), Ms anti-NEUN (Millipore #MAB377 1:100),
Rb anti-NG2 (Millipore # Ab5320), Rb anti-MOG (Proteintech # 12690-1-ap), Rb anti-IBA1 (Wako
#016-20001), Gp anti-VGLUT1 (Millipore #AB5905, 1:2000), Gp anti-VGLUT2 (Millipore #AB2251
1:3000, 1:5000), Rb anti-GLUA1 (Millipore #AB1504, 1:400), Rb anti-GLUA2 (Millipore #AB1768-I,
1:400), and Ms anti-Bassoon (Enzo #VAMP500, 1:500). All secondary antibodies were applied at
1:500 dilution.
The following mouse lines and antibody combinations were used:
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Experiment and figure #

Antibody targets

Cell marker colocalization RiboTag validation (Figure 1, Figure 1—figure
supplement 1)

HA, S100β, NEUN, IBA1,
NG2, MOG

Astrocyte number across development per layer (Figure 2, Figure 2—figure
supplement 1)

GFP, VGLUT2

Astrocyte marker colocalization with Aldh1l1-Gfp (Figure 2—figure supplement 1)

GFP, SOX9, S100β,
ALDH1L1

Presynaptic development per layer (Figure 3, Figure 3—figure supplement 1)

GFP, VGLUT1, VGLUT2

Postsynaptic development per layer (Figure 3)

GFP, GLUA1, GLUA2

Assessing the presence of thalamic projections to the VC in VGlut2 cKO mice
(Figure 4—figure supplement 2)

VGLUT2

Analysis of VGLUT1 and VGLUT2 signal in VGlut2 cKO mice (Figure 4, Figure 4—
figure supplement 2)

VGLUT1, VGLUT2

Quantification of pre and postsynaptic puncta, and synapses (Figure 4, Figure 4—
figure supplement 2, Figure 5, Figure 5—figure supplement 1)

VGLUT1, VGLUT2,
Bassoon, GLUA1, GLUA2

Single-molecule fluorescent in situ hybridization (smFISH)
All smFISH experiments reported here were performed on brain tissue fixed with 4% paraformaldehyde and processed using cryosectioning as described in the ‘Mouse tissue collection’ section. The
assay was performed using the RNAscope 2.5 HD—multiplex fluorescent Manual Assay kit (ACDbio
#320850) using the manufacturer’s instructions for fixed-frozen tissue with the following modifications. Directly following cryosectioning, slides containing brain sections were dried for 1 hr at –20° C,
then washed for 5 min in PBS at room temperature, followed by brief wash (~1 min) in 100% Molecular Biology Grade Ethanol. The slides were then air-dried for 5 min and incubated with appropriate
pretreatment reagents at 40° C. For tissue from P1 to P7 mice, slides were incubated with protease 3
for 30 min; for P14–P28, protease 4 30 min. Slides were then briefly washed with PBS and incubated
with target probes for 2 hr at 40° C, followed by three amplification steps and one detection step.
Slides were mounted using the SlowFade Gold with DAPI mounting media (LifeTech #S36939) covered
with 1.5 glass coverslip (Fisher #12544E) and sealed with clear nail polish. The original protocol can be
found in ACDbio website: https://acdbio.com/technical-support/user-manuals. Detailed step-by-step
modified protocol performed here is available upon request.
All slides were either imaged within 1–2 days or stored at –20° C until imaging.

Imaging and analysis
Fluorescent microscopy
Imaging was performed using an Axio Imager.Z2 fluorescent microscope (Zeiss) with the apotome
module (apotome 2.0) and AxioCam HR3 camera (Zeiss) at 20× magnification. Tile images that
contain the entire primary VC (from pial surface to white matter tract) were acquired. Number of tiles
adjusted to contain a similar area of the cortex at each developmental stage, typically 1–2 (width) ×
2–4 (depth) (pixel size 0.3 × 0.3 µm).
For RiboTag validation (Figure 1, Figure 1—figure supplement 1): Single-plane images were
obtained.
For in situ hybridization experiments (Figure 2, Figure 2—figure supplement 1): z-stack images
(seven slices, optical slice 1 µm) were obtained.
For developmental analysis of astrocyte numbers per layer (Figure 2, Figure 2—figure supplement 1), presynaptic marker analysis during development (Figure 3, Figure 3—figure supplement
1), VGlut2 cKO validation (Figure 4, Figure 4—figure supplement 2), and Aldh1l1-GFP mouse validation (Figure 2—figure supplement 1): z stack images (three slices, optical slice 1 µm) were obtained.

Confocal microscopy
Developmental analysis of GLUA1 and GLUA2 expression (Figure 3): Slides were imaged using Zeiss
LSM 700 confocal microscope at 63× magnification. A 1176 × 1176 pixel 2.7 μm thick z-stack image
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was obtained (pixel size 0.09 × 0.09 × 0.3 µm, 10 slices per 2.7 µm stack). In total, four images were
taken from each section to encompass all cortical layers. Layers 4–5 were combined into one image.
RORacre-tdTomato+ thalamic projections in the VC (Figure 4—figure supplement 2): Slides were
imaged using Zeiss LSM 700 confocal microscope at 63× magnification. A 900 × 900 pixels 2.7 µm
thick z-stack image was obtained (xyz size 0.11 × 0.11 × 0.3 µm, 10 slices per 2.7 µm stack). Separate
images were taken for layer 1 and layer 4.
Synapse number analysis (Figure 4, Figure 4—figure supplement 2, Figure 5, Figure 5—figure
supplement 1): Slides were imaged using Zeiss LSM 880 confocal microscope at 63× magnification.
For each section, 1420 × 920 pixels 3.5 µm thick z-stack image was obtained (pixel size 0.08 × 0.08
× 0.39 µm; 10 slices per 3.5 µm stack). All images were from layer 1. Example images show a single z
plane from the same location in the stack for both genotypes.
In all cases, when comparing WT and KO per given experiment, slides were imaged on the same
day using set exposure.

Image analysis
Image analysis was primarily done with ImageJ (FIJI, NIH) or Imaris (Bitplane) software as described
below for each section:
Cell marker colocalization RiboTag validation (Figure 1, Figure 1—figure supplement 1): This
was performed using FIJI (ImageJ). Thresholding was performed on the RiboTag-labeled image
(stained with an anti-
HA tag antibody), and the ‘Analyze Particles’ function was used with a
minimum area of 20–40 μm to automatically separate and quantify the total number of RiboTag-
positive cells. The number of double-labeled RiboTag and cell-type antibody-positive cells were
manually counted. This generated the proportion of RiboTag-positive cells that also label for the
cell-specific marker.
Astrocyte number across development per layer (Figure 2, Figure 2—figure supplement 1):
This was done on sections of Aldh1l1-GFP VC that were co-immunostained for VGLUT2 using semi-
automatic custom-made macro in ImageJ. For each image, maximal intensity projections were created,
then each cortical layer was manually cropped based on DAPI and VGLUT2 staining, and saved as a
separate file. Then, a colocalization file was created using the ‘colocalization threshold’ function to
merge the colocalized cell marked by DAPI with the Aldh1l1-GFP signal to specifically select astrocytes. Colocalized objects were counted using the ‘Analyze Particles’ function. Number of astrocytes
in each layer was recorded for each developmental stage.
The high cell density at early ages made it impossible to use a similar method to count the total
number of cells using the DAPI labels. Instead, three Regions of interest (ROIs) were created for each
layer, and cells were counted manually within each ROI, using the ‘multi-point’ tool in ImageJ. The
total cell number in each layer was then extrapolated based on the total area measurement in each
file.
Astrocyte marker colocalization with Aldh1l1-
Gfp (Figure 2—figure supplement 1): An ROI
containing the entire depth of the cortex of a maximal intensity projection image was cropped equally
for each image. Labeled cells were counted manually using the ‘cell counter’ plugin in ImageJ. Positively labeled cells were identified based on signal strength. For each file, three types of counts were
made: the appropriate astrocyte marker-positive cell number, Aldh1l1-GFP-positive cell number, and
colocalized cell number.
Spatio-temporal analysis of presynaptic proteins (Figure 3, Figure 3—figure supplement 1): This
was performed with ImageJ. As above, for each file, maximal intensity projections were created, then
layers were cropped out manually and saved as separate files. VGLUT signal was thresholded in the
same way for all images to contain all visible signal. The threshold area measurement was recorded
for each file.
Spatio-temporal analysis of postsynaptic proteins (Figure 3): This was performed using the Imaris
software (Bitplane). GLUA puncta number was calculated using the ‘spots’ function, and mean intensity filter to select the positive puncta. In all images, signals were thresholded in the same way. To
analyze specifically the GLUA signal in the cell processes and not the soma, cell bodies labeled by
DAPI were selected manually using the ‘create object’ function. Then GLUA puncta number that colocalized with cell bodies was quantified. Finally, cell body-related GLUA1 puncta were subtracted from
the total puncta number to obtain process-expressed GLUAs.
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Quantification of tdTomato+ thalamocortical projections in the VC (Figure 4—figure supplement
2): was performed using Imaris (Bitplane). tdTomato+ processes were rendered using the ‘create
object’ function. In all images, signals were thresholded in the same way to select labeled processes.
Total volume was calculated and compared between the experimental groups. VGLUT2 puncta were
rendered using the ‘create spots’ function, and mean intensity filter to threshold positive spots.
Analysis of VGLUT1 and VGLUT2 signal in VGlut2 cKO mice (Figure 4, Figure 4—figure supplement 2): was performed using ImageJ as described for developmental presynaptic experiments.
Counting astrocytes within each layer in VGlut2 cKO and Ip3r2 KO mice (Figure 4—figure supplement 2, Figure 5—figure supplement 1): was performed manually using the ‘cell counter’ plugin in
ImageJ using smFISH in situ images (see below). Astrocytes were identified by positive Slc1a3 probe
signal.
Quantification of smFISH signal (Figure 2, Figure 2—figure supplement 2, Figure 4, Figure 4—
figure supplement 1, Figure 5, Figure 5—figure supplement 1): was performed using a custom-
made macro in ImageJ. Maximal intensity projection images of the VC were manually cropped per
layer and saved as individual files. Astrocytes were identified using the GFP signal in experiments with
Aldh1l1-GFP mice (Figure 2, Figure 2—figure supplement 2); and Slc1a3 probe signal in all other
experiments (Figure 4, Figure 4—figure supplement 2, Figure 5, Figure 5—figure supplement
1). An ROI outline was then created around the cell body of the astrocyte, the signal of the probe of
interest was then thresholded in the same way for all images, and the threshold area was recorded
for each cell. This strategy was employed because we found that threshold area of the signal gave a
more reliable and stable result than intensity measurements, which are not recommended by smFISH
protocol (RNAscope by ACDbio). Moreover, due to the density of the signal in some cases, counting
individual puncta was impossible.
Quantification of pre-, postsynaptic puncta, and synapses (Figure 4, Figure 4—figure supplement
2, Figure 5, Figure 5—figure supplement 1): This was performed using Imaris software (Bitplane).
Positive puncta of GLUA1, GLUA2, VGLUT1, VGLUT2, Bassoon, and tdTomato processes (Figure 4—
figure supplement 2) were selected by size and intensity by thresholding the signal in the same
way for each section. Then colocalization between each two pre-postsynaptic pairs was calculated.
Puncta were considered colocalized if the distance between them was ≤0.5 µm (Blanco-Suarez et al.,
2018; Farhy-Tselnicker et al., 2017). For experiments described in Figure 4—figure supplement
2, first colocalization between tdTomato and Bassoon was established and cropped. The colocalized
Bassoon-tdTomato puncta were then used to calculate colocalization with GLUA1 or GLUA2. Number
of colocalized puncta was obtained and compared between the experimental groups. A minimum of
three sections per mouse were imaged for each brain region, and the experiment was repeated in at
least five WT and KO pairs. Example images show a single z plane from the same location in the stack
for both genotypes.

Data presentation and statistical analysis
All data is presented as either mean ± s.e.m., scatter with mean ± s.e.m., or scatter with range, as indicated in each figure legend. Statistical analysis was performed using Prism software (GraphPad) unless
otherwise stated in the text. Multiple group comparisons were done using one-way analysis of variance (ANOVA) with post hoc Tukey’s or Dunn’s tests. Pairwise comparisons were done by t-test. When
data did not pass the normal distribution test, multiple comparisons were done by Kruskal–Wallis
ANOVA on ranks and pairwise comparisons were done with the Mann–Whitney rank-sum test. p-Value
≤ 0.05 was considered statistically significant. Analysis was done blind to genotype. The sample sizes,
statistical tests used, and significance are presented in each figure and figure legend.
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in Figures 2-5 is available in Figure 2-5 Source Data files. Processed single nucleus RNA sequencing
data presented in Figure 6 is available in Figure 6-Source Data 1. The RNA sequencing data has been
deposited at GEO. Ribotag data is available at GSE161398 and glial snRNAseq at GSE163775.
Processed RNA sequencing data is available in a searchable format at the following web locations:
ribotag astrocyte developmental dataset: http://igc1.salk.edu:3838/astrocyte_transcriptome/; single
nucleus glial cell sequencing: http://mouse-astro-dev.cells.ucsc.edu/.
The following dataset was generated:
Author(s)

Year

Dataset title

Boisvert MM, Farhy-
Tselnicker I, Erikson
GA, Shokhirev MN,
Allen NJ

2021

Astrocyte developmental
https://www.ncbi.
transcriptome from mouse nlm.nih.gov/geo/
visual cortex
query/acc.cgi?acc=
GSE161398

NCBI Gene Expression
Omnibus, GSE161398

Activity-dependent
modulation of synapse-
regulating genes in
astrocytes

https://www.ncbi.
nlm.nih.gov/geo/
query/acc.cgi?acc=
GSE163775

NCBI Gene Expression
Omnibus, GSE163775

Farhy-Tselnicker I,
2021
Liu H, Shokhirev MN,
Ecker JR, Allen NJ

Dataset URL

Database and Identifier

The following previously published datasets were used:
Author(s)

Year

Dataset title

Dataset URL

Database and Identifier

Boisvert M, Allen N

2017

Astrocyte-enriched pan-
brain aging transcriptome

https://www.ncbi.
nlm.nih.gov/geo/
query/acc.cgi?acc=
GSE99791

NCBI Gene Expression
Omnibus, GSE99791
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